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 1 
INTRODUCTION 
 
 The success of endodontic treatment is directly influenced by 
elimination of microorganisms in infected root canals.11 Microorganisms 
that invade the root canal system have an essential role in initiating and 
sustaining periapical disease.47  
 Unlike primary endodontic infections, which are polymicrobial in 
nature and dominated by gram-negative anaerobic rods, the microorganisms 
involved in secondary infections are composed of one or a few bacterial 
species.60, 85, 36 Enterococcus faecalis is a persistent organism that, despite 
making up a small proportion of the flora in untreated canals, plays a major 
role in the etiology of persistent periradicular lesions after root canal 
treatment. It is commonly found in a high percentage of root canal failures 
and it is able to survive in the root canal as a single organism or as a major 
component of the flora.22 Studies investigating its occurrence in root-filled 
teeth with periradicular lesions have demonstrated a prevalence ranging 
from 24 to 77%.36, 60, 67, 68, 70, 71, 78, 85 Starvation increases the resistance of      
E. faecalis 1000-fold to 10,000-fold. It is probable that the physiologic state 
of the cells, particularly in retreatment cases, is closest to the starvation 
phase.72 
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 The majority of infecting bacteria, together with their principal 
substrate of necrotic pulp debris, might be reduced significantly by 
chemomechanical instrumentation.27, 57 However, this is not always achieved 
completely as a result of the anatomic complexity and diversity of root 
canals, as well as the subsequent limitations in access by instruments and 
irrigants.46, 69, 82 Therefore, the use of an intracanal medication can help 
eliminate the bacteria remaining even after chemomechanical 
instrumentation and can provide an environment conducive to periapical 
tissue repair.16 
 Calcium hydroxide has been used as an intracanal medicament for a 
long time. The effects of calcium hydroxide [Ca(OH)2] in root canal and 
dentin disinfection are well documented. The antimicrobial effects of 
Ca(OH)2 may be directly related to its high alkalinity and a great majority of 
the microbial species isolated from root canals show susceptibility both 
clinically and ex vivo (Bystrom & Sundqvist 1981, 1983, Bystrom et al. 
1985, Waltimo et al. 2005). However, several studies demonstrated that 
Ca(OH)2 fails to eradicate Enterococcus faecalis residing in infected root 
canal systems (Bystrom et al. 1985, Haapasalo & Ørstavik 1987, Safavi et 
al. 1990, Ørstavik & Haapasalo 1990, Evans et al. 2002, Peters et al. 2002, 
Weiger et al. 2002, Saleh et al. 2004). An explanation for the resistance 
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against Ca(OH)2 might be the ability of  E. faecalis to invade dentinal 
tubules, isthmuses and other ramifications of a root canal system (Love 
2001). Furthermore, it has been documented to be able to survive for 
prolonged periods in high alkalinity (Bystrom et al. 1985, Haapasalo & 
Ørstavik 1987) and harsh nutrient conditions (Hartke et al. 1998, Figdor et 
al. 2003, Portenier et al. 2005). Evans et al. (2002) reported the survival of       
E. faecalis at high pH was due to a functioning proton pump with the 
capacity to acidify cytoplasm. On the other hand, the buffering capacity of 
dentin can inhibit the pH increase and the antimicrobial activity of Ca(OH)2 
in the root canal (Haapasalo et al. 2000).  
 Many alternative antimicrobial agents have been tested for their 
ability to eliminate E. faecalis from the root canal system. In vitro studies 
have indicated that chlorhexidine may be potent in the elimination of           
E. faecelis from the root canal system (Bystrom et al.1985, Haapasalo & 
Ørstavik 1987, Ørstavik & Haapasalo 1990, Basrani et al. 2003, Gomes et al. 
2003). 
 It is active against a wide range of microorganisms, such as Gram-
positive and Gram-negative bacteria.30 CHX has an antibacterial efficacy 
comparable to that of sodium hypochlorite (NaOCl).65 In addition, it is also 
effective against strains resistant to Ca(OH)2. CHX may also impart 
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substantive antibacterial activity to root dentin after prolonged (ie, at least 1 
week) exposure.5, 37, 50, 52, 96 2% CHX is proved to be an efficient agent 
against E. faecalis.44  
 Finding healing powers in plants is an ancient idea. Medicinal plants 
are part and parcel of human society to combat diseases, from the dawn of 
civilization.14 They constitute a promising source of phytotherapy drugs and 
new molecules.23 Their beneficial effects allied to the current worldwide 
“back to nature” trend have led to greater attention being paid to these 
products.29 Numerous studies have identified compounds within herbs that 
are effective antibiotics (Basile et al., 2000; Cowan, 1999). Traditional 
healing systems around the world that utilize herbal remedies are important 
resources for the discovery of new antibiotics (Okpekon et al., 2004). 
Certain traditional remedies have already been reported to be effective 
against drug-resistant bacteria (Kone et al., 2004; Sato et al., 2000). 
 Interestingly, the effects of fruit extracts on bacteria have been studied 
by numerous researchers world-wide (Reddy et al., 2001; Erdoorul, 2002; 
Atefl and Erdoorul, 2003). In addition, much work has been focused on 
ethnomedicinal plants in India (Maheshwari et al., 1986; Rai, 1989; Negi et 
al., 1993). It has been suggested that ethanol and aqueous extracts from 
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plants are potential sources of antimicrobial agents (Chung et al., 1995; 
Vlietinck et al., 1995).86 
    The increasing failure of chemotherapeutics and antibiotic resistance 
exhibited by pathogenic microbial infectious agents have lead to the 
screening of several medicinal plants for their potential antimicrobial 
activity.77 Herbal medicines are in great demand in the developed as well as 
developing countries for primary healthcare because of their wide biological 
and medicinal activities, higher safety margins and lesser costs.14 The 
number of studies on this alternative therapeutic system increased in the last 
decades, as well as their use for several purposes.23 
 Triphala is a traditional Siddha herbal formulation consisting of the 
dried fruits of three medicinal plants Terminalia chebula, Terminalia 
bellerica and Phyllanthus emblica, also known as the three myrobalans. 
Triphala means three (tri) fruits (phala). It is reported to have various 
biological activities as: Anti-oxidant, Anti-cancer, Anti-mutagenic, 
Immunomodulatory, Anti-allergic, Radioprotective, Adaptogenic, 
Cardiotonic, Hypocholesterolaemic, Capillary strengthening, 
Hepatoprotective, Anti-bacterial, Anti-viral, Anti-fungal, Anti-malarial.41, 76 
 Terminalia chebula is one of the constituents of Triphala. Terminalia 
chebula is a plant species belonging to the genous Terminalia, family 
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Combretaceae. It is a flowering evergreen tree called in English the black 
myrobalan. It is also known as Haritaki (Sanskrit and Bengali), Harad 
(Hindi), Karkchettu (Telugu), Kadukkai (Tamil), Harada (Marathi & 
Gujrati). It is native to Indian subcontinent and the adjacent areas such as 
Pakistan, Nepal and the South-West of China stretching as far south as 
Kerala or even Sri Lanka where it is called Aralu. The fruit of the tree has 
been used as traditional medicine for household remedy against various 
human ailments, since antiquity. Terminalia chebula has been extensively 
used in Indian medicine and has become a cynosure of modern medicine.14
 Antibacterial activity of Terminalia chebula against both Gram 
positive and Gram negative human pathogenic bacteria has also been 
reported. Aqueous extract of Terminalia chebula exhibits antifungal activity 
against a number of dermatophytes and yeasts. It is effective against the 
pathogenic yeast Candida albicans.94 
 This knowledge would enable more rational exploitation of this plant 
material both in traditional medicine and in the empirical development of 
new antimicrobials. The present systematic and methodical investigations 
have therefore been designed to elucidate the possible antibacterial activity 
of alcoholic extracts of Triphala and Terminalia chebula against E. faecalis 
and its potential to be used as an intracanal medicament to eliminate            
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E. faecalis from infected root canals and aid in the ultimate success of 
endodontic treatment. 
 8 
AIMS & OBJECTIVES 
 
1. To evaluate the potential of antimicrobial activity of Triphala and 
T. chebula against E. faecalis, by,  
 - Assessment of Minimum Inhibitory Concentration (MIC) of   
    Triphala and T. chebula against E. faecalis. 
 - Assessment of the levels of susceptibility of E. faecalis to Triphala,    
    T. chebula and CHX by measuring the zone of inhibition. 
 
2. To evaluate the potential of Triphala & T. chebula to be used as an 
intracanal medicament, against E. faecalis biofilms formed on dentin 
samples, by, 
 - Assessing the antimicrobial activity at 200 µm and 400 µm depths   
    by Colony Count (CFU/ml) and Optical Density values (OD)    
    measured using spectrophotometer. 
 - Comparative evaluation of the activity of these herbal extracts with     
    2% CHX. 
 
 
 
 9 
REVIEW OF LITERATURE 
Enterococcus faecalis & Intracanal Medicaments: 
 Haapasalo et al. (1987)35 developed an in vitro model for dentinal 
tubule infection of root canals. Cylindrical dentin specimens, 4mm high with 
a diameter of 6 mm and a canal 2.3 mm wide, were prepared from freshly 
extracted bovine incisors. The cementum was removed from all dentin 
blocks. The tubules were opened by four-minute treatments with 17% EDTA 
and 5.2% NaOCl before being infected with Entercoccus faecalis ATCC 
29212 in yeast extract-glucose broth. Bacteria rapidly invaded the tubules. 
After three weeks of incubation, a heavy infection was found 400 µm from 
the canal lumen and the front of the infection reached 1000 µm in some 
blocks. Camphorated paramonochlorophenol (CMC) and a calcium 
hydroxide compound, Calasept, were tested for their disinfecting efficacy 
toward E. faecallis – infected dentin. Liquid CMCP rapidly and completely 
disinfected tubules, whereas CMCP in gaseous form disinfected tubules less 
rapidly. Calasept failed to eliminate, even superficially, E. faecalis in the 
tubules. The method used in bacteriological sampling allowed for sequential 
removal of 100 µm thick zones of dentin from the central canal towards the 
periphery. The control specimens were uniformly infected and yielded 
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growth in bur samples up to some 500 µm from the surface. The model 
proved quite sensitive and seems suitable for in vitro testing of root canal 
medicaments. 
 Chong et al. (1992)16  discussed the role of intracanal medication as a 
root canal dressing. They stated that in pulpectomy and some root canal 
treatments, where the root canal contains vital pulp tissue, it is doubtful 
whether a routine intracanal medicament is needed. In infected root canals, 
intracanal medication has been advocated for many purposes. An intracanal 
medicament is used to: (i) eliminate any remaining bacteria after canal 
instrumentation; (ii) reduce inflammation of periapical tissues and pulp 
remnants; (iii) render canal contents inert and neutralize tissue debris; (iv) 
act as a barrier against leakage from the temporary filling; (v) help to dry 
persistently wet canals. The authors concluded that intracanal medicaments 
should only be used for root canal disinfection as part of controlled asepsis 
in infected root canals, and their role is secondary to cleaning and shaping of 
the root canal. Thorough canal debridement and adequate canal preparation 
are more pertinent and their importance is emphasized. Bacteriological 
sampling may be necessary if a tooth does not respond to treatment, to help 
in the choice of intracanal medicament. 
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 Gomes et al. (1996)32 studied variation in the susceptibilities of 
endodontic microflora to chemical procedures and confirmed that organisms 
like E. faecalis were recovered from canals after thorough Bio Mechanical 
Preparations. He concluded certain organisms like E. faecalis are difficult to 
be eliminated from infected root canals. 
 Sundqvist et al. (1998)88 conducted a study to determine what 
microbial flora were present in teeth after failed root canal therapy and to 
establish the outcome of conservative re-treatment. Fifty-four root-filled 
teeth with persisting periapical lesions were selected for re-treatment. After 
removal of the root filling, canals were sampled by means of advanced 
microbiologic techniques. The teeth were then re-treated and followed for up 
to 5 years. The results showed that the microbial flora was mainly single 
species of predominantly gram-positive organisms. The isolates most 
commonly recovered were bacteria of the species Enterococcus faecalis. The 
overall success rate of re-treatment was 74%. They concluded that the 
microbial flora in canals after failed endodontic therapy differed markedly 
from the flora in untreated teeth. Infection at the time of root filling and size 
of the periapical lesion were factors that had a negative influence on the 
prognosis. Three of four endodontic failures were successfully managed by 
re-treatment. 
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 Lima et al. (2001)49 conducted an in vitro study to evaluate the 
effectiveness of chlorhexidine- or antibiotics-based medications in 
eliminating E. faecalis biofilms using Biofilm Susceptibility Assay. One-day 
and three-day biofilms of E. faecalis were induced on cellulose nitrate 
membrane filters.  Each biofilm-containing membrane was thoroughly 
covered with 1 ml of the test medications and incubated for 1 day at 37°C. 
Treated biofilms were then aseptically transferred to vials containing a 
neutralizing agent in saline solution and vortexed. Suspensions were 10-fold 
diluted, seeded onto Mitts salivarius agar plates, and the colony-forming 
units counted after 48 h of incubation. The results of the study showed that 
there were significant differences between the formulations tested. The 
association of clindamycin with metronidazole significantly reduced the 
number of cells in 1-day biofilms. However of all medications tested, only 
2% chlorhexidine-containing medications were able to thoroughly eliminate 
most of both 1-day and 3-day E. faecalis biofilms. The authors concluded 
that chlorhexidine may exert an important role in the eradication of 
endodontic infection associated with teeth that were refractory to 
conventional endodontic therapy. 
 Love et al. (2001)55 postulated that virulence factor of E. faecalis in 
failed endodontically treated teeth may be related to the ability of E. faecalis 
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cells to maintain the capability to invade dentinal tubules and adhere to 
collagen in the presence of human serum. E. faecalis virulence may also be 
related to its resistance to intracanal medicaments, adherence to host cells, 
expression of protein to ensure cell survival as a result of altered nutrient 
supply, ability to compete with other bacterial cells, alter host response and 
environment. 
 Bettina Basrani et al. (2002)7 conducted an in vitro study to assess 
the substantive antimicrobial activity of different medicaments in human 
root dentin using spectrophotometric analysis of optical density. Canals of 
98 roots were enlarged to standard size and medicated for 7 days with the 
following: (1) 2% chlorhexidine (CHX) gel, (2) 0.2% CHX gel, (3) 2% CHX 
solution, (4) Ca(OH)2, (5) Ca(OH)2+ 0.2% CHX gel, (6) 2% CHX solution 
+ a 25% CHX-containing controlled-release device, (7) saline and (8) gel 
vehicle. After medication, canals were inoculated with Enterococcus faecalis 
for 21 days. Dentin samples were collected with Gates-Glidden burs into 
brain heart infusion broth and bacterial growth was assessed with 
spectrophotometric analysis of optical density after 72 hours of incubation. 
The results of the study showed that mean optical densities were 
significantly lower for groups with 2% CHX (1,3, and 6) when compared 
with those of the controls Other groups did not differ significantly from the 
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controls. The authors concluded that canal dressing for 1 week with 2% CI 
IX may provide residual antimicrobial activity against E. faecalis. 
 Cruz et al. (2002)18 conducted an in vitro study to evaluate the 
penetration of propylene glycol into root dentine. Safranin O in propylene 
glycol and in distilled water was introduced into root canals with and 
without artificial smear layer. Dye diffusion through dentinal tubules was 
determined spectrophotometrically. The time required for dye to exit 
through the apical foramen using propylene glycol and distilled water as 
vehicles was also determined. The extent and areas of dye penetration on the 
split surfaces of roots were assessed using Adobe Photoshop and NTH 
Image Software. The results of the study showed that propylene glycol 
allowed dye to exit faster through the apical foramen. The area and depth of 
dye penetration with propylene glycol was significantly greater than with 
distilled water. Smear layer significantly delayed the penetration of dye. The 
authors concluded that propylene glycol delivered dye through the root canal 
system rapidly and more effectively indicating its potential use in delivering 
intracanal medicaments. 
 Bettina Basrani et al. (2003)6 conducted an in vitro study to assess 
the antimicrobial activity of different medicaments in human root dentin. 
The effect of CHX (0.2% and 2% in gel or solution) and Ca(OH)2 (alone or 
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with 0.2% CHX gel) was evaluated by using the agar diffusion test and an in 
vitro human  root inoculation method, to measure zone of inhibition or 
bacterial growth with optical density by spectrophotometric analysis, 
respectively. For optical density analysis, samples from infected root canals 
were collected after 7 days of medication and were cultured for 24 hours in 
brain-heart infusion to detect viable bacteria. In the agar diffusion test, CHX 
was effective against E faecalis in a concentration-dependent fashion, but 
Ca(OH)2 alone had no effect. In the root canal inoculation test, CHX was 
significantly more effective against E faecalis than Ca(OH)2 was (P < .05), 
but there were no significant differences between the modes of medication 
or concentrations of CHX. The authors concluded that CHX is effective 
against E faecalis in vitro. Further in vivo studies are needed to confirm the 
value of CHX in clinical treatment. 
 Gomes et al. (2003)34 evaluated the effectiveness of 2% chlorhexidine 
gluconate gel and calcium hydroxide as intracanal medicaments against 
E.faecalis. The specimens were divided into four groups, according to the 
intracanal medicament used, as follows: Group 1: 2% chlorhexidine 
gluconate gel; Group 2: calcium hydroxide in a viscous vehicle 
(polyethylene glycol 400); Group 3: 2% chlorhexidine gluconate 
gel+calcium hydroxide and Group 4: Brain Heart Infusion (BHI) broth 
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(control group). The medicaments were placed into the canal lumen and left 
there for experimental times of 1, 2, 7, 15 and 30 days. The results of the 
study showed that chlorhexidine gel alone completely inhibited the growth 
of E.faecalis after 1,2,7 and 15 days. Calcium hydroxide allowed microbial 
growth at  all  experimental  times.  The combination of chlorhexidine and 
calcium hydroxide was effective after 1 and 2 days demonstrating 100% 
antibacterial action; however, its antibacterial activity reduced between 7 
and 15 days. The authors concluded that under the conditions of this study, 
2% chlorhexidine gel alone was more effective against E. faecalis than 
calcium hydroxide. However, its antibacterial activity depended on how long 
it remained inside the root canal. 
 Isabelle Portenier et al. (2003)40 Stated that in the past few years, 
Enterococcus faecalis has been the focus of increased interest both in 
medicine and dentistry and a recognized pathogen in post-treatment 
endodontic infections, E. faecalis is frequently isolated both in mixed flora 
and in monocultures. E. faecalis is probably the species that can best adapt to 
and tolerate the ecologically demanding conditions in the filled root canal. 
Eradication of E. faecalis from the root canal with chemomechanical 
preparation and using disinfecting irrigants and antibacterial dressings is 
difficult. They concluded that in endodontics, E. faecalis is rarely present in 
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primary apical periodontitis, but it is the dominant microorganism in root-
filled teeth presenting with post-treatment apical periodontitis. It is often 
isolated from the root canal in pure culture, but it can also be found together 
with some other bacteria or yeasts. When in mixed infections, E. faecalis 
typically is the dominant isolate. While there is no doubt about the 
pathogenicity of E. faecalis in endodontic infections, it seems to be rarely 
associated with acute infections and flare-ups. Eradication of E. faecalis 
from the root canal remains a challenge, while chlorhexidine and 
combinations of disinfectants show some promise. 
 Vivacqua-Gomes et al. (2005)93 conducted a study to assess the 
presence of Enterococcus faecalis after root canal treatment in single or 
multiple visits in an ex vivo model. Forty-five premolar teeth were infected 
ex vivo with E.faecalis for 60 days. The canals were then prepared and 
irrigated with 2% chlorhexidine gel. The specimens were divided into five 
groups (Gl, G2, G3, G4 and G5) according to the time elapsed between 
chemical-mechanical preparation and root canal filling, the irrigant solution 
used and the use or nonuse of a calcium hydroxide intracanal medicament. 
The teeth were then root-filled and incubated for 60 days at 37°C. Dentine 
chips were removed from the canal walls with sequential sterile round burs 
at low speed. The samples obtained with each bur were immediately 
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collected in separate test tubes containing Brain-Heart Infusion broth. These 
samples were placed onto agar plates and colony forming units were counted 
after 24 hours at 37°C. The results of the study showed that Enterococcus 
faecalis was recovered from all die five groups, with the lowest count being 
of Gl (chlorhexidine irrigation and immediate root filling in a single visit). 
The authors concluded that neither single- nor multiple-visit root canal 
treatment ex vivo, eliminated E. faecalis completely from dentinal tubules. 
Up to 60 days after root filling, E. faecalis remained viable inside dentinal 
tubules. When no sealer was used, E. faecalis presented a higher growth rate. 
 Kayaoglu et al. (2005)48 conducted an in vitro study to evaluate the 
effect of growth at pH levels from 7.1 to 9.5 on the adherence of 
Enterococcus faecalis to bovine serum albumin (BSA) and collagen type I. 
Enterococcus faecalis strain A197A was grown in broth of adjusted pHs 
varying between 7.1 and 9.5. Aliquots of bacterial suspensions were added 
to wells coated either with BSA or with collagen type I. Bacteria adhering   
to   the   surfaces   were   stained   with   crystal   violet. Spectrophotometric 
measurements of the dissolved stain were used to assess the number of 
bacteria adhering to the surfaces. The results of the study showed that the 
adhesion of E. faecalis to BSA-coated surfaces decreased inversely with 
alkalinity of the growth medium. The pH 7.1-grown bacteria bound to BSA 
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significantly more than the other BSA groups. On the contrary, the adhesion 
to collagen type I-coated surfaces of bacteria grown at pH 8.0 and 8.5 was 
significantly greater than for those grown at pH 7.1. The authors concluded 
that a minor increase in pH up to 8.5, which may be a consequence of 
insufficient treatment with alkaline medicaments such as calcium hydroxide, 
increases the collagen-binding ability of E. faecalis, in vitro. This can be a 
critical mechanism by which E. faecalis predominates in persistent 
endodontic infections. 
 Edgar Schafer et al. (2005)19 conducted an in vitro study to 
investigate the efficacy of chlorhexidine (CHX) and calcium hydroxide 
(Ca(OH)2) against Enterococcus faecalis using culture plate method by 
counting the colony forming units. Extracted single-rooted human teeth were 
instrumented up to size 40. After removal of the smear layer, an inoculum of 
E. faecalis was inserted into the root canals. After incubation, the inoculum 
was removed and the root canals were filled with one of three different 
disinfectants. Ca(OH)2 paste, CHX 2%, and a mixture of CHX and 
Ca(OH)2 paste (n = 10 in each group). Control teeth were filled with water 
of standardized hardness (n = 10). The teeth were then incubated for 3 days. 
After incubation, each root canal was instrumented, and the removed dentin 
was examined microbiologically. The results of the study showed that CHX 
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was significantly more effective against E. faecalis than was Ca(OH)2 paste 
or a mixture of CHX with Ca(OH)2 paste. There was no increase in the 
efficiency of Ca(OH)2 paste when CHX was added. The authors concluded 
that the results suggest that CHX is effective in the elimination of E. faecalis 
from dentinal tubules. 
 Sedgley et al. (2005)9 studied survival of E. faecalis in root canals 
environment. Enterococcus faecalis inoculated into root canals maintained 
viability for 12-months ex vivo. The clinical implications are that viable E. 
faecalis entombed at the time of root filling could provide a long-term nidus 
for subsequent infection. The conclusion of this study was that E. faecalis 
entombed at the time of root filling could provide a long term nidus for 
subsequent infection. 
 Ferrari et al. (2005)25 attempted to detect enterococci, enteric 
bacteria and yeast species from the canals of teeth with primary endodontic 
infections before and after canal preparation. They concluded that 
Enterococci, enteric bacteria and yeasts were present in primary endodontic 
infections. Enterococci, particularly Enterococcus faecalis and E. faecium 
were resistant to removal by root canal preparation followed by intracanal 
dressing. 
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 George et al. (2005)28 studied the role of environmental changes on 
monospecies biofilm formation on root canal wall by E.faecalis. The bioflim 
mode of growth is a survival strategy and harsh environmental conditions 
existing in root canal may favor the growth of bacteria as a biofilm. This 
aspect is supported by the fact that clinically isolated E. faecalis possess 
increased adhering capacity, increased virulence factor & increased 
resistance to antimicrobials that are all characteristics of biofilm style of 
growth. In this study, it was concluded that biofilm forming capacity of 
microorganisms depends upon the surface attributes of the substratum and 
can vary according to prevailing environmental and nutritional conditions. 
 Sathorn et al. (2006)10 discussed to what extent does calcium 
hydroxide intracanal medication eliminate bacteria from human root canals, 
compared with the same canals before medication, as measured by the 
number of positive cultures, in patients undergoing root canal treatment for 
apical periodontitis. The results showed that in eight studies included in the 
review, covering 257 cases; sample size varied from 18 to 60 cases; six 
studies demonstrated a statistically significant difference between pre-and 
post-medicated canals, whilst two did not. There was considerable 
heterogeneity among studies. The difference between pre- and post-
medication was not statistically significant. The authors concluded that 
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Calcium hydroxide has limited effectiveness in eliminating bacteria from 
human root canal when assessed by culture techniques. The quest for better 
antibacterial protocols and sampling techniques must continue to ensure that 
bacteria have been reliably eradicated prior to obturation. 
 Ertugrul Ercan et al. (2006)21  conducted an in vitro study to 
compare the effectiveness of various medicaments, including Ca(OH)2 with 
2% chlorhexidine, 2% chlorhexidine gel and Ca(OH)2 alone,  against 
Enterococcus faecalis and Candida albicans by counting the colony forming 
units . Eighty extracted single-rooted human maxillary teeth were taken and 
instrumented. The root canal was irrigated with EDTA solution to remove 
smear layer. Then, roots were infected with E.faecalis and C.albicans. 
Subsequently, the roots were divided into 4 treatment groups: group 1 was 
treated with calcium powder hydroxide in distilled water, group 2 was 
treated with calcium hydroxide powder in 2% chlorhexidine, group 3 was 
treated with 2% chlorhexidine gel and group 4 was treated with 0.9% sterile 
saline serving as negative control. Microbial samples were taken after 7, 15 
and 30 days. After incubation, dentine chips were obtained from each root 
canal and examined microbiologically  The microbiological samples were 
plated to count colony-forming units in per milligram of dentin The results 
of the study showed that the 2% chlorhexidine gel was significantly more 
 23 
effective than calcium hydroxide with 2% chlorhexidine, calcium hydroxide 
with distilled water and control saline solution. The authors concluded that 
under the conditions of this study, 2% chlorhexidine gel is effective in the 
elimination of E.faecalis calls and    C.albicans from the root canal system. 
However, to support this in vitro observation, further in vivo studies are 
needed. 
 Lisane Paquette et  al. (2007)53  conducted an in vivo study to assess 
the antibacterial efficacy of intracanal medication with 2% chlorhexidine 
liquid (CHX) in teeth with apical periodontitis. Canals in 22 teeth were 
instrumented at the first session, medicated with CHX and reaccessed after 7 
to 15 days. Bacteriological samples were aspirated at the first and second 
sessions,   before   (1A,   2A)   and   after   (IB,   2B)   canal instrumentation. 
Viable bacterial counts were obtained by culture (CFU) and microscopy 
using vital dyes. The results of the study showed that microscopic counts 
were higher than CFU counts. Consistently high CFU counts in 1A samples 
decreased significantly in IB samples, increased significantly in 2A samples 
and decreased in 2B samples to the level of IB samples. Proportions of 
negative cultures followed the pattern of CFU counts. Intracanal medication 
with chlorhexidine did not reduce the bacterial concentration.  The authors 
concluded that 2% chlorhexidine gluconate liquid applied in vivo as 
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intracanal medication for 7 days to 15 days did not increase the proportion of 
teeth with negative cultures or reduce the bacterial counts beyond that 
achieved after chemomechanical preparation in the first treatment session. 
Although the bacterial regrowth was less than in historic controls, the 
potential benefits of CHX indicated by in vitro studies were not fully 
realized. Thus, further research is warranted on different delivery forms of 
chlorhexidine, as well as alternative intracanal medications.  
 Wang et al. (2007)15 conducted a study to evaluate the clinical 
efficacy of 2% chlorhexidine (CHX) gel on intracanal bacteria reduction 
during root canal instrumentation using culture plate method by counting the 
colony forming units. The additional antibacterial effect of an intracanal 
dressing (Ca[OH]2 mixed with 2% CHX gel) was also assessed. Forty-three 
patients with apical periodontitis were recruited. Four patients with 
irreversible pulpitis were included as negative controls. Teeth were 
instrumented using rotary instruments and 2% chlorhexidine gel as the 
disinfectant. Bacterial samples were taken upon access (SI), after 
instrumentation (S2) and after 2 weeks of intracanal dressing (S3). 
Anaerobic culture was performed. The results of the study showed that four 
samples showed no bacteria growth at S1, which were excluded from further 
analysis. Of the samples cultured positively at SI, 10.3% (4/39) and 8.3% 
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(4/36) sampled bacteria at S2 and S3, respectively. A significant difference 
in the percentage of positive culture between SI and S2 but not between S2 
and S3 was found. The authors concluded that the results suggest that 2% 
chlorhexidine gel is an effective root canal disinfectant and additional 
intracanal dressing did not significantly improve the bacteria reduction on 
the sampled root canals. 
 Jogikalmat Krithikadatta et al. (2007)44  conducted an in vitro study 
to evaluate the disinfection of dentinal tubules using 2% chlorhexidine gel, 
2% metronidazole gel, bioactive glass (S53P4) in comparison with calcium 
hydroxide. The antibacterial efficacy of the four medicaments against 
Enterococcus faecalis was assessed in Vitro using culture plate method by 
counting the colony forming units in extracted premolar teeth at the depths 
of 200 µm and 400 µm. The results of the study showed that the overall 
percentage inhibition of bacterial growth (at 200 µm and 400 µm depth) was 
100% with 2% chlorhexidine gel. The inhibition of growth was moderate 
with 2% metronidazole gel (86.5%), followed by bioactive glass (62.8%) 
and calcium hydroxide (58.5%).   The authors from the present study 
concluded that 2% chlorhexidine gel alone was most effective against E. 
faecalis when compared to other medicaments tested. 
 26 
 Souza-Filho et al. (2008)26  conducted an in vitro study to evaluate 
the effectiveness of 2% chlorhexidine (CHX) gluconate gel, calcium 
hydroxide [Ca(OH)2] and their combination with iodoform and zinc oxide 
powder as intracanal medications against select microorganisms using agar 
diffusion method and to measure the pH changes caused by these 
medications. The zones of growth inhibition were measured. The pH of the 
pastes was measured right after preparation, after 24 h and 1 week later. The 
results of the study showed that the largest mean zones of microbial 
inhibition were produced by 2% CHX gel, followed by Ca(OH)2 + 2% CHX 
gel + iodoform, Ca(OH)2 + 2% CHX gel, Ca(OH)2 + 2% CHX gel + zinc 
oxide and Ca(OH)2 + water. The mean pH of all medications stayed above 
12.0 during the whole experiment, except for chlorhexidine gel (pH=7.0). 
All medications had antimicrobial activity, but the most effective against the 
tested microorganisms were 2% chlorhexidine gel, followed by its 
combination with Ca(OH)2 and iodoform. The authors concluded that 
Ca(OH)2 associated with 2% chlorhexidine, with or without iodoform or 
zinc oxide, when used as an intracanal medication provides antimicrobial 
action and is able to maintain an ideal pH. 
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Herbal Extracts: 
Ahmad et al. (1998)3 subjected a total of 82 Indian medicinal plants 
traditionally used in medicines to preliminary antibacterial screening, against 
several pathogenic and opportunistic microorganisms. Aqueous, hexane and 
alcoholic extracts of each plant were tested for their antibacterial activity 
using agar well diffusion method at sample concentration of 200 mg/ml. The 
results indicated that out of 82 plants, 56 exhibited antibacterial activity 
against one or more test pathogens. Interestingly, extracts of five plants 
showed strong and broad spectrum activity as compared to rest of 51 plant 
extracts which demonstrated moderate activity. On the whole the alcoholic 
extracts showed greater activity than their corresponding aqueous and 
hexane extracts. Among various extracts, only alcoholic extracts of Emblica 
officinalis, Terminalia chebula, Terminalia bellerica, Plumbago zeylanica 
and Holarrhena antidysenterica were found to show potentially interesting 
activity against test bacteria. These active crude alcoholic extracts were also 
assayed for cellular toxicity to fresh sheep erythrocytes and found to have no 
cellular toxicity. 
Jagtap et al. (1999)41 conducted a study to test the ability of the aqueous 
extract of T. chebula to inhibit the growth and some physiological functions 
of Streptococcus mutans. The extract strongly inhibited the growth, sucrose 
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induced adherence and glucan induced aggregation of S. mutans. Mouth 
rinsing with a 10% solution of the extract inhibited the salivary bacterial 
count and salivary glycolysis. Mouth rinsing with the extract significantly 
reduced total bacterial counts and the total streptococcal counts in the saliva 
samples obtained up to and including 3 h after rinsing, compared with the 
counts obtained pre-rinsing or after placebo rinsing. The extract successfully 
inhibited glycolysis of salivary bacteria for up to 90 min post-rinsing. 
Naik et al. (2004)63 conducted a study to assess the potential antioxidant 
activity of aqueous extract of a natural herb, Terminalia chebula by 
examining its ability to inhibit γ-radiation-induced lipid peroxidation in rat 
liver microsomes and damage to superoxide dismutase enzyme in rat liver 
mitochondria. The antimutagenic activity of the extract has been examined 
by following the inhibition of γ-radiation-induced strand breaks formation in 
plasmid pBR322 DNA. In order to understand the phytochemicals 
responsible for this, HPLC analysis of the extract was carried out, which 
showed the presence of compounds such as ascorbate, gallic acid and ellagic 
acid. This was also confirmed by cyclic voltammetry. The extract inhibits 
xanthine/xanthine oxidase activity and is also an excellent scavenger of 
DPPH radicals. The rate at which the extract and its constituents scavenge 
the DPPH radical was studied by using stopped-flow kinetic spectrometer. 
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Based on all these results it is concluded that the aqueous extract of T. 
chebula acts as a potent antioxidant and since it is able to protect cellular 
organelles from the radiation-induced damage, it may be considered as a 
probable radioprotector. 
K.M. Elizabeth. (2005)20 conducted a study to assess the antimicrobial 
activity of crude and methanol extract of Terminalia bellerica dry fruit by 
disc diffusion method, against 9 human microbial pathogens. Crude aqueous 
extract of dry fruit at 4 mg concentration showed zone of inhibition ranging 
from 15.5-28.0 mm. S. aureus was found to be highly susceptible forming 
highest zone of inhibition, suggesting that T. bellerica was strongly 
inhibitory towards this organism. These pathogens were highly sensitive to 
the methanol extract forming 14.0 to 30.0 mm zone of inhibition suggesting 
that the methanol extract of T. bellerica was more effective than crude 
extract against most of the microbes tested except E. coli (enteropathogen) 
and P. aeruginosa. The minimal inhibitory concentrations (MICs) of crude 
and methanol extracts were determined by broth dilution technique which 
ranged from 300 to >2400 µg/ml and 250 µg to >2000 µg/ml respectively, 
indicating that T. bellerica was highly effective against S. aureus with lower 
MIC values. There were some biochemical alterations induced by T. 
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bellerica. These results indicate that T. bellerica dry fruit possesses potential 
broad spectrum antimicrobial activity. 
Hyun-Sun LEE et al. (2005)38 stated that The ripe fruit of Terminalia 
chebula RETZIUS (T. chebula RETZ) (Combretsceae), which is a native 
plant in India and Southeast Asia, has traditionally been used as a popular 
folk medicine for homeostatic, antitussive, laxative, diuretic, and cardiotonic 
treatments. They conducted a study to evaluate the protective effects of an 
aqueous extract of fruit of T. chebula on the tert-butyl hydroperoxide (t-
BHP)-induced oxidative injury observed in cultured rat primary hepatocytes 
and rat liver. Both treatment and pretreatment of the hepatocytes 
with the T. chebula extract (TCE) significantly reversed the t-BHP-induced 
cell cytotoxicity and lactate dehydrogenase leakage. In addition, TCE 
exhibited in vitro ferric-reducing antioxidant activity and 2,2-diphenyl-1-
picryhydrazyl free radical-scavenging activities. The in vivo study showed 
that pretreatment with TCE (500 or 1000 mg/kg) by gavage for 5 d before a 
single dose of t-BHP (0.1 mmol/kg i.p.) significantly lowered the serum 
levels of the hepatic enzyme markers aspartate aminotransferase and alanine 
aminotransferase and reduced the indicators of oxidative stress in the liver, 
such as the glutathine disulfide content and lipid peroxidation, in a dose 
dependent manner. Histopathologic examination of the rat livers showed that 
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TCE reduced the incidence of liver lesions, including hepatocyte swelling 
and neutrophilic infiltration, and repaired necrosis induced by t-BHP. Based 
on the results described above, we speculate that TCE has the potential to 
play a role in the hepatic prevention of oxidative damage in living systems. 
Tasduq et al. (2006)90 stated that Terminalia chebula  (Combetraceae) is an 
important herbal drug in Ayurvedic pharmacopea. In their study, a 95% 
ethanolic extract of T. chebula (fruit) (TC extract), which was chemically 
characterized on the basis of chebuloside II as a marker, was investigated for 
hepatoprotective activity against anti-tuberculosis (anti-TB) drug-induced 
toxicity. TC extract was found to prevent the hepatotoxicity caused by the 
administration of rifampicin (RIF), isoniazid (INH) and pyrazinamide (PZA) 
(in combination) in a sub-chronic mode (12 weeks). The hepatoprotective 
effect of TC extract could be attributed to its prominent anti-oxidative and 
membrane stabilizing activities. The changes in biochemical observations 
were supported by histological profile. 
Srikumar et al. (2007)87 stated that, the isolation of microbial agents less 
susceptible to regular antibiotics and the rising trend in the recovery rates of 
resistant bacteria highlights the need for newer alternative principles. 
Triphala has been used in traditional medicine practice against certain 
diseases such as jaundice, fever, cough, eye diseases etc. In their study 
 32 
phytochemical (phenolic, flavonoid and carotenoid) and antibacterial 
activities of aqueous and ethanol extracts of Triphala and its individual 
components (Terminalia chebula, Terminalia bellerica and Emblica 
officinalis) were tested against certain bacterial isolates (Pseudomonas 
aeruginosa, Klebsiella pneumoniae, Shigella sonnei, S. flexneri, 
Staphylococcus aureus, Vibrio cholerae, Salmonella paratyphi-B, 
Escherichia coli, Enterococcus faecalis, Salmonella typhi) obtained from 
HIV infected patients using Kirby-Bauer’s disk diffusion and minimum 
inhibitory concentration (MIC) methods. T. chebula was found to possess 
high phytochemical content followed by T. bellerica and E. officinalis in 
both aqueous and ethanol extracts. Further, most of the bacterial isolates 
were inhibited by the ethanol and aqueous extracts of T. chebula followed by 
T. bellerica and E. officinalis by both disk diffusion and MIC methods. It 
revealed that both individual and combined aqueous and ethanol extracts of 
Triphala have antibacterial activity against the bacterial isolates tested. 
Chattopadhyay et al. (2007)14 stated that Terminalia chebula is a great herb 
with lack of extensive research studies. Despite this fact it has been in use as 
the most frequently used herb in Ayurveda. They studied the antibacterial 
activity of aqueous, hexane and ethanol extracts of black myrobalan (fruit of 
Terminalia chebula Retz.) by agar-well diffusion method against 
 33 
uropathogen Escherichia coli of clinical origin. It was observed that both 
aqueous and ethanolic extracts showed strong (IZD = 21+1.41mm – 24.0 
mm) and hexane extract mild (IZD = 9+1.41 mm) zone of inhibition against 
the strain evaluated. The minimal inhibitory concentration (MIC) values in 
macrobroth dilution assay technique of aqueous and ethanolic extracts were 
6.25 mg/ml and 3.12 mg/ml respectively. Minimal bactericidal concentration 
(MBC) values were two to four fold higher than the corresponding MIC 
values and the total activity of the aqueous and ethanolic extracts were 67.5 
ml and 154.7 ml respectively. Thus, both aqueous and ethanolic extracts of 
black myrobalan were strongly inhibitory towards the uropathogen E. coli 
with bactericidal activity ( MBC ranging from 6.25 mg/ml to 25.0 mg/ml) 
against the test strain and ethanolic extract was found to possesses highest 
antibacterial activity in comparison with its aqueous counterpart on the basis 
of their MIC index and total activity values and these findings reinforce the 
importance of ethnomedical approach as a potential source of bioactive 
substances against urinary tract infections caused by first major bacterial 
culprit Escherichia coli. 
Rasool et al. (2007)75 Attempted to evaluate the antiarthritic effect of the 
Indian Ayurvedic herbal formulation Triphala on adjuvant-induced arthritis 
in mice and to compare it with that of the non-steroidal antiinflammatory 
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drug indomethacin. Triphala (1 g/kg/bxwt) and indomethacin (3 
mg/kg/bxwt) were administered orally for 8 days (from day 11 to 18) after 
adjuvant injection. The levels of lysosomal enzymes, tissue marker enzymes, 
glycoproteins and paw thickness were increased in adjuvant-induced 
arthritic animals. The body weight was found to be reduced when compared 
with the control animals. These physical and biochemical changes observed 
in arthritic animals were altered significantly to near normal conditions after 
oral administration of Triphala (1 g/kg/b.wt). The results obtained clearly 
indicate the fact that the Indian Ayurvedic herbal formulation Triphala has 
promising anti-inflammatory activity. 
Usha et al. (2007)12 stated that Plant-derived medicines have been a part of 
our traditional health care system, and the antimicrobial properties of plant-
derived compounds are well documented. They conducted a study to 
evaluate the effect of an aqueous extract of Terminalia chebula (a medicinal 
plant) on salivary samples and its potential for use as an anticaries agent in 
the form of mouthwash. A concentrated aqueous extract was prepared from 
the fruit of T. chebula. A mouth rinse of 10% concentration was prepared by 
diluting the extract in sterile distilled water. The efficacy of the mouth rinse 
was assessed by testing on 50 salivary samples. Salivary samples were 
collected from subjects assessed to be at high risk for caries. Salivary pH, 
 35 
buffering capacity, and microbial activity were assessed before rinsing, 
immediately after, and 10 min. 30 min. and 1 h after rinsing. There was an 
increase in the pH and buffering capacity and decrease in microbial count. 
An aqueous extract of T. chebula used as a mouth rinse seems to be an 
effective anticaries agent. 
Biradar et al. (2008)97 conducted a study to evaluate Antimicrobial activity 
of aqueous and alcoholic extracts of both Triphala and Triphala Mashi. 
Comparative phytochemical profile of Triphala and Triphala Mashi was 
done by preliminary phytochemical screening, total phenolic content and 
thin layer chromatography (TLC). Antimicrobial activity includes isolation 
of pathogens from clinical samples, its characterization, testing its multiple 
drug resistance against standard antibiotics and antimicrobial activity of 
aqueous and alcoholic extracts of both Triphala and Triphala Mashi against 
these organisms by using agar gel diffusion method. They concluded that 
Triphala Mashi containing phenolic compounds, tannins exhibited 
comparable antimicrobial activity in relation to Triphala against all the 
microorganisms tested. It inhibits the dose-dependent growth of Gram-
positive and Gram-negative bacteria. 
Kumar et al. (2008)51 Infection is a major problem in the management of 
wounds. Even though the development of synthetic antimicrobial agents 
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persists, drug resistance and toxicity hinder their way. Many plants with 
multi-potent pharmaceutical activities may offer better treatment options, 
and Triphala (dried fruits of Terminalia chebula, Terminalia bellirica, and 
Phyllanthus emblica) are potential formulations evaluated for healing 
activity on infected wound as it possesses numerous activities. Alcoholic 
extract of Triphala has shown in vitro antimicrobial activity against wound 
pathogens such as Staphylococcus aureus, Pseudomonas aeruginosa, and 
Streptococcus pyogenes. In their study an ointment was prepared from the 
Triphala extract (10% w/w) and assessed for in vivo wound healing on 
infected rat model by rate of healing, bacterial count, biochemical analysis, 
and expression of matrix metalloproteinases. The treated group showed 
significantly improved wound closure. Assessment of granulation tissue on 
every fourth day showed significant reduction in bacterial count with 
significant level of collagen, hexosamine, uronic acid, and superoxide 
dismutase in the treated group (P < 0.01). Reduction of matrix 
metalloproteinase expression observed in the treated group by gelatin 
zymography and immunoblotting confirmed the in vivo assessment. They 
concluded that the results showed the antibacterial, wound healing, and 
antioxidant activities of Triphala ointment, necessary for the management of 
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infected wounds. Active principles of the Triphala may be further evaluated 
and used as an excellent therapeutic formulation for infected wounds. 
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ARMAMENTARIUM 
 
• Culture Plates 
• Tripticase Soy broth & agar (Hi Media) 
• E. faecalis (ATCC 29212) 
• Alcoholic extract of Triphala & T. chebula (Elles Aromatics) 
• Chlorhexidine gluconate (Dentachlor) 
• Amoxicillin 
• Dimethyl Sulfoxide - DMSO (Fischer) 
• 28 freshly extracted single rooted human teeth 
• Straight hand piece (NSK) 
• Contra-angled handpiece (NSK) 
• Diamond disk 
• K-files (Mani) 
• Gates gliddin – ISO size 1, 2, 3, 4 & 5 (Mani) 
• 5% NaOCl (prime dent) 
• 17% EDTA (pulp dent) 
• Saline (0.9% w/v) 
• Ultrasonic bath 
• Autoclave 
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• Incubator (Dalal) 
• Laminar Flow 
• Micropipette 
• Microcentrifuge tube (Tarson) 
• Propylene glycol (Fischer) 
• Methyl cellulose 
• Glass slab & Spatula 
• Hand plugger 
• Sticky Wax 
• Digital colony counter (Dalal) 
• Spectrophotometer (Bio-Rad) 
• Sterile gloves 
• Mask 
 
  
 
ASSESSMENT OF MIC 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Stock solution of Triphala & T. chebula prepared by 
dissolving 1500mg of extract in 7.5ml of DMSO 
Extracts incorporated in TS agar to obtain culture 
plates with various concentrations & the test group 
& positive controls were spot inoculated. 
Test group (TS agar + 
Extract) 
1.20mg/ml   
2.40mg/ml 
3.60mg/ml   
All plates were incubated at 37oC for 24 hours. 
Positive control 
(1. Plain TS 
agar, 2. TS agar 
with DMSO) 
Negative control 
(TS Agar + 
Extract, without 
inoculation)   
No growth was found for Triphala & T. chebula 
starting at 20mg/ml and 40mg/ml respectively. 
To find the possibility of lower value for MIC, extracts 
with 100mg/ml concentration were prepared. 
Extracts incorporated in TS agar to obtain 
concentrations as,  
Triphala – 20, 10, 5 & 2.5 mg/ml. 
T. chebula – 20, 25, 30, 35 mg/ml. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
MIC was confirmed as – 20mg/ml for Triphala &  
30mg/ml for T. chebula. 
 
Purity of the growth if present was confirmed by 
Colony morphology, Gram staining, Biochemical tests 
& Heat test as E. faecalis. 
All plates were incubated at 37oC for 24 hours and 
plates assessed for growth 
Bactericidal nature of these concentrations were 
confirmed by subculturing 
For Triphala – NO growth was found from 20mg/ml  
& 
For T. chebula – NO growth was found from 30mg/ml. 
 
Culture spot inoculated on the plates and positive and 
negative control were maintained. 
 SUSCEPTIBILITY TEST BY WELL DIFFUSION 
 
 
 
  
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
100µm of the inoculum mixed with 20ml of Mueller-
Hinton agar  
Held at 40 for 30 mins to aid in diffusion of the 
substances  
5 wells of 6mm diameter were punched.100µl of the 
antimicrobial agents & control were transferred to it. 
2% CHX 
30µgm of 
amoxicillin DMSO T. chebula Triphala
  
Incubated at 370c for 24 hrs  
Zone of inhibition around the wells were measured in 
mm & recorded 
ASSESSMENT OF ANTIMICROBIAL ACTIVITY 
AGAINST E.FAECALIS BIOFILM IN TEETH SAMPLES 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
28 single rooted human teeth were taken. 
Smear layer removed with 5% NaOCl for 5 mins, 
followed by 17% EDTA for 5 mins, 5% NaOCl for 5mins 
in an ultrasonic bath and then kept in saline for 5mins in 
an ultrasonic bath. 
Decoronated below CEJ & apical portion cut to obtain 
6mm of middle third of the root. 
All specimens were autoclaved at 1210 C for 15mins 
 
 
Cementum removed to standardize the external diameter 
to 4 mm & internal diameter standardize to GG no. 3. 
Blocks immersed in 1ml of TS broth in individual 
microcentrifuge tube & subjected to second cycle of 
sterilization 
 
 
24 samples were contaminated with E. faecalis (ATCC 
29212) 
50µl of the inoculum transferred to individual 
microcentrifuge tubes containing 1ml of TS broth and 
dentine block  
  
 
 
 
Dentine blocks transferred to fresh broth containing E. 
faecalis every second day for 21 days 
After 21 days, they were irrigated with saline & assigned to 
the following groups. 
Group 1: 
Positive control 
(n=6) 
All were incubated at 370C for 7 days. 
Antimicrobial assessment was done at the end of 7days, 
after irrigation with 5ml of saline. 
Dentine debris was harvested at 2 depths (200 & 400µm) by 
using GG no. 4 & 5 respectively & collected in 1 ml of 
sterile TS broth and incubated for 24 hrs. 
Antimicrobial assessment was done by measuring the OD 
value and recorded. 
The broth was serially diluted , plated & colonies were 
counted & recorded (CFU/ml). 
Test Groups 
Group2 : Triphala (n=6) 
Group3: T. chebula (n=6) 
Group4: CHX (n=6) 
Group 5: 
Negative  control 
(n=4) 
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METHODOLOGY 
  
 E. faecalis (ATCC 29212) maintained in stock culture in Institute of 
Microbiology, Madras Medical College was used in this study. 24 hr growth 
of E. faecalis grown on Trypticase Soy (TS) agar slope was suspended in 
5ml of TS broth and incubated for 4 hours at 370C. The culture suspension 
was adjusted to match the turbidity equivalent to 0.5 McFarland Standard.44 
This was used as the standardized inoculum for all the procedures. 
HERBAL EXTRACTS: 
 Alcoholic extract of Triphala and T. chebula was procured (Elles 
Aromatics, India). To find the activity of the extract against E. faecalis, the 
extracts were dissolved in Dimethyl Sulfoxide (DMSO), which is an inert 
organic solvent and does not have any antibacterial action on its own.14  
 Initially to find the Minimum Inhibitory Concentration (MIC), serial 
ten-fold dilutions were made to obtain a concentration range from 0.01 to 
1000 µg / ml for each extract in TS broth. Then 0.02 ml of the 0.5 
McFarland culture suspension was added to them. Two control tubes were 
maintained. These included a positive control (the tube containing the 
growth medium, physiological saline and the inoculum) and a negative 
control (tube containing extract and the growth medium without inoculum). 
The tubes were incubated at 370C for 24 hours. Then 0.1 ml of culture 
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medium from each tube was subcultured on fresh TS agar plates and 
incubated for 24 hours. All the plates had growth of microorganisms. This 
revealed that the concentration tried was insufficient to exhibit antimicrobial 
activity. Then several attempts were made with various concentration ranges 
(upto 15mg/ml), to find the MIC. 
 Finally, a stock solution was prepared by dissolving 1500mg of 
extract in 7.5ml of DMSO. The extracts were incorporated in the TS agar 
and culture plates were prepared with concentration ranging from 20mg/ml 
to 80mg/ml of the extracts by proportioning as in the table.  
Extract  Agar   Net concentration of Extract present 
0.5 ml + 4.5 ml = 20 mg/ml 
1 ml  + 4 ml  = 40 mg/ml 
1.5 ml + 3.5 ml = 60 mg/ml 
2 ml  + 3 ml  = 80 mg/ml 
 Then the culture was spot inoculated on the plates. Positive control 
was maintained by inoculating a plain TS agar plate without any 
antibacterial agent. Negative controls were obtained by maintaining an 
extract incorporated plate and DMSO control (TS agar plate with DMSO) 
without inoculation of culture over it. The plates were incubated at 370C for 
24 hours.  
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 The plates were assessed for presence or absence of microbial growth. 
When growth was present, the organism was confirmed as E. faecalis by 
colony morphology, gram straining, heat test and standard biochemical 
tests.17  
 Colony Morphology – It formed small (0.5 to 1 mm) clear colonies on 
TS agar.  
 Gram Staining – It was seen as gram positive cocci, occurring in 
ovoid pairs or in short chains.  
 Biochemical Tests – Biochemical reactions of it was assessed and it 
showed : 
  Arabinose    - 
  Mannitol    + 
  Raffinose     - 
  Sorbitol    + 
  Urease    + 
  NH3 produced from arginine + 
  Bile Esculin Test   + 
 Heat Test – It showed growth, even after heating the culture 
suspension at 600C for 30 mins. 
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 All of these features confirmed that the growth that was present in 
some of the plates was pure culture of E. faecalis. 
 To confirm the bactericidal nature of that particular concentration, 
samples were taken from the spotted region with a platinum loop and 
subcultured on a TS agar plate and incubated for 24 hrs at 370C and 
observed for the presence or absence of growth.  
 The concentration in which growth was present or absent was noted. 
The readings were as follows: 
 Concentration (mg/ml)  Triphala  T. chebula 
    of extract 
  20    NG   G   
  40    NG   NG 
  60    NG   NG 
  80    NG   NG 
 At that point of the experiment, no growth was seen from 20 mg/ml of 
extract concentration for Triphala and 40 mg/ml extract concentration for T. 
chebula. To explore the possibility of activity at even a slightly lower 
concentration, the extract with concentration of 100 mg/ml was used to 
prepare plates with concentrations ranging as in the table. 
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  Triphala 
  Extract  Agar  Net concentration of extract 
  1 ml  + 4 ml  = 20 mg 
  0.5 ml + 4.5 ml = 10 mg 
  0.25 ml + 4.75 ml = 5 mg 
  0.125 ml + 4.875 ml = 2.5 mg 
 
  T. chebula 
  Extract  Agar  Net concentration of extract 
  1 ml  + 4 ml  = 20 mg 
  1.25 ml + 3.75 ml = 25 mg 
  1.5 ml + 3.5 ml = 30 mg 
  1.75 ml + 3.25 ml = 35 mg 
 The culture plates were spot inoculated, incubated, assessed for 
growth of organism and subcultured for confirmation of bactericidal activity 
and the growth when present was assessed for purity of the culture, as done 
previously.  
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 MIC was taken as the lowest concentration in which no growth was 
detected. The readings were as follows. 
  Triphala     T. chebula 
  20 mg / ml  NG   20 mg / ml  G 
  10 mg / ml  G   25 mg / ml  G 
  5 mg / ml  G   30 mg / ml  NG  
  2.5 mg / ml  G   35 mg / ml  NG 
 So, the MIC of Triphala was found to be 20 mg / ml and for T. 
chebula 30 mg / ml. 
SUSCEPTIBILITY TEST BY WELL DIFFUSION METHOD 
 100 µl of inoculum adjusted to 0.5 McFarland was mixed in 20 ml of 
Mueller-Hinton agar and shaken. 0.5µg/ml of methylene blue was added to 
it, to impart colour to the medium, which may aid in the ease of assessment 
of the readings. Then the media was poured in a sterilized petridish . 5 wells 
of 6 mm diameter were punched into the agar medium with sterile metal 
cylinder. 100 µl of the extracts dissolved in DMSO, adjusted to the 
concentration of MIC was transferred to the wells. 100 µl of 2 % 
chlorhexidine and 30 µg of amoxicillin in the wells served as positive 
control and DMSO served as negative control. After holding the plates at 
40C for 30 mins to aid in diffusion of the antimicrobial agents into the 
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medium,2 they were incubated at 370C for 24 hours and then the diameter of 
zone of microbial growth inhibition around the wells were measured in 
millimeters and recorded. 
 
ASSESSMENT OF ANTIMICROBIAL ACTIVITY AGAINST  
E. FAECALIS BIOFILM IN THE TEETH SPECIMENS: 
 The dentin block model used in the experiment was modified from the 
one developed by Haapasalo and Orstavik (1987). In the present study, 
extracted human teeth were used instead of bovine incisors (Safavi et al, 
1990; Weiger et al, 2002; Lui et al, 2004; Saleh et al, 2004)89. Freshly 
extracted single rooted human teeth stored in 10 % formalin were used.  
Preparation of The Dentin Blocks: 
 A rotary diamond disk was used to decoronate the teeth below the 
cemento-enamel junction. The remaining root was then sectioned such that 6 
mm of the middle third of the root was obtained. Cementum was removed 
from the root surface for standardizing the external diameter to 4 mm. The 
internal diameter was standardized to Gates Glidden 3 (Mani Inc, Tachigi – 
Ken, Japan) in a slow speed handpiece (NSK, Tokyo, Japan).44 Organic and 
inorganic debris was removed by treating the blocks in an ultrasonic bath 
with 5% sodium hypochlorite for 5 mins, followed by 17% Ethylenediamine 
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tetra-acetic acid for 5 mins and again with 5% sodium hypochlorite for 5 
mins. The blocks were immersed in the ultrasonic bath of saline for 5 mins 
to remove all the traces of the chemicals used and sterilized in an autoclave 
at 1210C for 15 mins. The blocks were subjected to a second cycle of 
sterilization with the blocks immersed in 1 ml of Trypticase Soy (TS) broth 
in individual microcentrifuge tubes. This allows better penetration of the 
broth into the dentinal tubules.44 
Infecting the Dentin Blocks: 
 50 µl of the 0.5 McFarland inoculum of E. faecalis was transferred to 
presterilized individual microcentrifuge tubes contating 1 ml of the TS broth 
and dentin block. The dentin blocks were transferred to the fresh broth 
containing E. faecalis every second day. All the procedures were carried out 
under laminar flow. The purity of the culture was checked by subculturing 5 
µl of the broth from the incubated dentin block in TS broth on TS agar 
plates. The dentin blocks were infected for a period of 21 days.44  
Antimicrobial Assessment:  
 After the incubation period, the blocks were irrigated with 5 ml of 
sterile saline to remove the incubation broth. Then the dentin blocks were 
assigned to the following groups, each containing 6 blocks for the first 4 
groups and 4 blocks for group 5. 
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Group 1 - Positive control (Infected dentin blocks with saline  
   treatment). 
Group 2 - Triphala  
Group 3 - T. chebula 
Group 4 - Chlorhexidine (CHX) 
Group 5 - Negative control (Sterile dentin blocks with saline   
   treatment). 
 According to Fava and Saunders (1999), the antibacterial activity of 
intracanal medicament is enhanced by the vehicle used.24 So, propylene 
glycol (Fischer) was used as a solvent. 3 gm of extracts were dissolved in 3 
ml of propylene glycol, to be used as an intracanal medicament in group 2 
and 3. 2% CHX was used in group 4. Methyl cellulose was used as 
thickening agent,44 to obtain a paste like consistency, for the extracts and 
CHX. This was carried into the canal by using a sterile file and condensed 
with a hand plugger. All of the blocks after medication were sealed above 
and below with sticky wax and put in individual microcentrifuge tubes (all 
performed inside a laminar flow chamber) and incubated at 370C. The 
medicament was left in place for 7 days and antimicrobial assessment was 
performed after it. Then the blocks were washed with 5 ml of sterile saline.  
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 Dentin debris was harvested at 2 depths (200 µm and 400 µm) by 
using Gates-Glidden drills number 4 and 5 (Mani, Inc) respectively and 
collected in 1 ml of sterile TS broth in individual microcentrifuge tubes and 
incubated at 370C for 24 hours. After the incubation period, to measure 
optical density of the broth, 300 µl of it was transferred from each tube into 
the microtiter plate and optical density measured using spectrophotometer 
(Bio-Rad) at 620 nm. The OD readings were adjusted to the OD value of 
fresh and sterile broth as a blank. 
 In order to assess the number of colony forming units, the broth was 
serially diluted, plated on TS agar plates and incubated at 370C for 24 hours 
and the CFU were counted and recorded (CFU/ml). 
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RESULTS & STATISTICAL ANALYSIS 
I. The values of zone of inhibition produced are presented in Table 1.1. 
 
Table 1.1 - Zone of Inhibition (mm)   
Triphala 45 46 45 
T. chebula 48 49 47 
CHX 25 23 27 
Amoxicillin 20 18 21 
DMSO 0 0 0 
     
 The data were analysed by Oneway Anova followed by Tukey – HSD 
(Post-Hoc) multiple comparison test and Kruskal-Wallis test.  
Table 1.2 - ANOVA 
  Mean SD 
Triphala 45.33 0.577 
T. chebula 48 1 
CHX 25 2 
Amoxicillin 19.67 1.528 
DMSO 0 0 
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Table 1.3 - TUKEY – HSD MULTIPLE COMPARISONS 
Comparisons Mean Difference p value 
Triphala vs T. chebula -2.667 > 0.05 
Triphala vs CHX 20.333 < 0.001 
Triphala vs AMOX 25.667 < 0.001 
Triphala vs DMSO 45.333 < 0.001 
T. chebula vs CHX 23.000 < 0.001 
T. chebula vs AMOX 28.333 < 0.001 
T. chebula vs DMSO 48.000 < 0.001 
CHX vs AMOX 5.333 < 0.01 
CHX vs DMSO 25.000 < 0.001 
AMOX vs DMSO 19.667 < 0.001 
 
Table 1.4 - KURSKAL – WALLIS TEST 
  Mean Rank p value 
Triphala 11 
T. chebula 14 
CHX 8 
Amoxicillin 5 
DMSO 2 
< 0.01 
 
 
INFERENCE 
• All the antimicrobial agents showed high statistically 
significant difference (p < 0.001) when compared with DMSO. 
• There was no statistically significant difference between 
Triphala and T. chebula (p > 0.05) 
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• Triphala and T. chebula showed high significant difference     
(p < 0.001) when compared with Amoxicillin and CHX. 
• CHX showed significant difference (p < 0.01) when compared 
with Amoxicillin. 
 
II. The OD Values measured for all the groups at 200 µm & 400 µm 
are presented in the Table 2.1 & 2.2. 
Table 2.1 – OD Values (200 µm) 
Group 1 0.474 0.482 0.486 0.461 0.419 0.456 
Group 2 0.003 0 0.001 0.002 0 0 
Group 3 0 0.002 0.002 0.001 0 0.001 
Group 4 0 0.001 0.002 0.001 0.001 0.003 
Group 5 0.001 0 0.002 0.001  - -  
 
Table 2.2 – OD Values (400 µm) 
Group 1 0.468 0.462 0.473 0.458 0.42 0.459 
Group 2 0 0.002 0 0.001 0.003 0 
Group 3 0.002 0 0.001 0 0.001 0.001 
Group 4 0.001 0.028 0.011 0.026 0.042 0.018 
Group 5 0 0.001 0 0.002 -  - 
 
 The data were statistically analysed using Oneway Anova followed by 
Tukey – HSD (Post-Hoc) multiple comparison test and Kruskal-Wallis 
test was done for non-parametric data. 
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Table 2.3 – ANOVA (OD Values) 
200 µm 400 µm 
Groups Mean SD Mean SD 
Group 1 0.46300 0.024495 0.45667 0.018843 
Group 2 0.00100 0.001265 0.00100 0.001265 
Group 3 0.00100 0.000894 0.00083 0.000753 
Group 4 0.00133 0.001033 0.02100 0.014311 
Group 5 0.00100 0.000816 0.00075 0.000957 
 
 
Table 2.4 - TUKEY – HSD MULTIPLE COMPARISONS  
200 µm 400 µm 
Goups 
Comparison 
Mean 
Difference p value 
Mean 
Difference p value 
G1 vs G2 0.462000 < 0.001 0.455667 < 0.001 
G1 vs G3 0.462000 < 0.001 0.455833 < 0.001 
G1 vs G4 0.461667 < 0.001 0.435667 < 0.001 
G1 vs G5 0.462000 < 0.001 0.455917 < 0.001 
G2 vs G3 0.000000 > 0.05 0.000167 > 0.05 
G2 vs G4 -0.000333 > 0.05 -0.020000 < 0.05 
G2 vs G5 0.000000 > 0.05 0.000250 > 0.05 
G3 vs G4 -0.000333 > 0.05 -0.020167 < 0.05 
G3 vs G5 0.000000 > 0.05 0.000083 > 0.05 
G4 vs G5 0.000333 > 0.05 0.020250 > 0.05 
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Table 2.5 – KRUSKAL – WALLIS TEST (OD Values) 
200 µm 400 µm 
Goups 
Mean rank p value Mean rank p value 
Group 1 25.50 25.50 
Group 2 10.50 9.08 
Group 3 11.17 9.08 
Group 4 13.00 18.42 
Group 5 11.25 
< 0.01 
8.38 
< 0.001 
 
INFERENCE 
At 200µm: 
• Group 1 showed highly significant difference (p < 0.001) when 
compared with all other groups.  
• Group 2, 3, 4 & 5 did not show any significant difference (p > 0.05) 
among them at 200µm. 
 
At 400µm: 
• Group 1 showed highly significant difference (p < 0.001) when 
compared with all other groups. 
• Group 2 & 3 did not show any statistically significant difference       
(p > 0.05) between them and when compared with Group 5. 
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• Group 2 & 3 had statistically significant difference (p < 0.05) when 
compared with Group 4. 
 
 
III. The CFU / ml values measured for all the groups at 200 µm & 
400 µm are presented in the Table 3.1 & 3.2. 
Table 3.1 – CFU / ml Values (200 µm) 
Group 1 
(x 109) 156 168 170 148 142 154 
Group 2 0 0 0 0 0 0 
Group 3 0 0 0 0 0 0 
Group 4 0 0 0 0 0 0 
Group 5 0 0 0 0 -  - 
 
 
Table 3.2 – CFU / ml Values (400 µm) 
Group 1 
(x 109)  148 152 164 152 150 160 
Group 2 0 0 0 0 0 0 
Group 3 0 0 0 0 0 0 
Group 4 0 10 0 10 20 0 
Group 5 0 0 0 0 -  - 
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Table 3.3 - ANOVA (CFU / ml) 
200 µm 400 µm 
Groups Mean SD Mean SD 
Group 1 
(x 109) 156.33 10.985 154.33 6.250 
Group 2 0.00 0.000 0.00 0.000 
Group 3 0.00 0.000 0.00 0.000 
Group 4 0.00 0.000 6.67 8.165 
Group 5 0.00 0.000 0.00 0.000 
 
Table 3.4 - TUKEY – HSD MULTIPLE COMPARISONS  
200 µm 400 µm 
Groups 
Comparison Mean 
Difference p value 
Mean 
Difference p value 
G1 vs G2  
156.333  
x 109 < 0.001 
154.333  
x 109 < 0.001 
G1 vs G3 
156.333  
x 109 < 0.001 
154.333 
x 109 < 0.001 
G1 vs G4 
156.333 
x 109 < 0.001 
147.667 
x 109 < 0.001 
G1 vs G5 
156.333 
x 109 < 0.001 
154.333 
x 109 < 0.001 
G2 vs G3 0.000 > 0.05 0.000 > 0.05 
G2 vs G4 0.000 > 0.05 -6.667 > 0.05 
G2 vs G5 0.000 > 0.05 0.000 > 0.05 
G3 vs G4 0.000 > 0.05 -6.667 > 0.05 
G3 vs G5 0.000 > 0.05 0.000 > 0.05 
G4 vs G5 0.000 > 0.05 6.667 > 0.05 
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Table 3.5 – KRUSKAL – WALLIS TEST (CFU / ml Values) 
200 µm 400 µm 
Groups 
Mean rank p value Mean rank p value 
Group 1 25.50 25.50 
Group 2 11.50 10.00 
Group 3 11.50 10.00 
Group 4 11.50 15.50 
Group 5 11.50 
< 0.001 
10.00 
< 0.001 
 
INFERENCE  
At 200 µm & 400 µm: 
• Group 1 showed highly significant difference (p < 0.001) when 
compared with all the other groups. 
• Group 2, 3, 4 & 5 didn’t have any statistical significance (p > 0.05) 
among them. 
 
IV. OD values and CFU / ml at 200 µm & 400 µm for each individual 
group were compared using independent sample test (Student t-test). 
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Table 4.1 – Independent Samples Test (Student t-Test) 
CFU / ml OD 
Groups Mean SD p value Mean SD 
p 
value 
200µm 156.33 x 109 
10.98484  
x 109 
0.46300 
x 109 
0.0245  
x 109 Group 1 
400µm 154.33 x 109 
6.25033 
x 109 > 0.05 
0.45670 
x 109 
0.0188 
x 109 > 0.05 
200µm 0 0 0.00100 0.0013 Group 2 
400µm 0 0 > 0.05 0.00100 0.0013 > 0.05 
200µm 0 0 0.00100 0.0009 Group 3 
400µm 0 0 > 0.05 0.00083 0.0008 > 0.05 
200µm 0 0 0.00133 0.0013 Group 4 
400µm 6.6667 8.16497 > 0.05 0.02100 0.0143 < 0.05 
200µm 0 0 0.00100 0.0008 Group 5 
400µm 0 0 > 0.05 0.00075 0.001 > 0.05 
 
 
 
Table 4.2 – Mann-Whitney Test 
  p value 
CFU OD 
200 & 
400 
200 & 
400 Group 4 
> 0.05 < 0.05 
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INFERENCE 
• There was no statistically significant difference (p > 0.05) between 
200µm & 400µm values, when assessed by OD or CFU / ml in Group 
1, 2, 3    & 5. 
• In Group 4, there was no statistical significance (p > 0.05) between 
the 200 µm & 400 µm values, when assessed by CFU / ml. But, there 
was statistically significant difference (p < 0.05) when OD values 
were analysed.  
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INFERENCE OF THE STUDY 
I Zone of Inhibition: 
• All the antimicrobial agents showed high statistically 
significant difference (p < 0.001) when compared with DMSO. 
• There was no statistically significant difference between 
Triphala and T. chebula (p > 0.05) 
• Triphala and T. chebula showed high significant difference     
(p < 0.001) when compared with Amoxicillin and CHX. 
• CHX showed significant difference (p < 0.01) when compared 
with Amoxicillin. 
II OD Values: 
• Group 1 showed highly significant difference (p < 0.001) when 
compared with all other groups at 200 & 400 µm.  
• Group 2, 3, 4 & 5 did not show any significant difference (p > 0.05) 
among them at 200µm. 
• Group 2 & 3 did not show any statistically significant difference       
(p > 0.05) between them and when compared with Group 5. 
• Group 2 & 3 had statistically significant difference (p < 0.05) when 
compared with Group 4. 
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• In groups 1, 2, 3 & 5 there was no statistically significant difference 
(p > 0.05) between 200 & 400 µm values, within a group, when 
assessed by OD values. 
• There was statistically significant difference (p < 0.05) between 200 
& 400 µm values in Group 4. 
 
III CFU/ml Values: 
• Group 1 showed highly significant difference (p < 0.001) when 
compared with all the other groups. 
• Group 2, 3, 4 & 5 didn’t have any statistical significance (p > 0.05) 
among them. 
• In all the groups there was no statistically significant difference 
between 200 µm & 400 µm values, within a group, when assessed by 
CFU/ml. 
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DISCUSSION 
 
 Microorganisms play a fundamental role in the etiology of pulp 
and periapical diseases. Their control and elimination are important 
during endodontic treatment.47 E. faecalis is probably the species that can 
best adapt to and tolerate the ecologically demanding conditions in the 
filled root canals. It is resistant to various antimicrobials. It is considered 
as a ‘star’ in post-treatment disease.40 Because of this the development of 
effective therapeutic modalities against E. faecalis is desirable. Hence     
E. faecalis was chosen for the inoculum in this study. In addition,            
E. faecalis is relatively easy to culture and it has been used successfully in 
most studies with the original model.5, 37, 50, 52, 66 
 Various modalities are attempted to eliminate residual bacteria 
from the root canal, which includes high end technologies as with 
LASERS, PAD and ANILAD. Even though these show promising results, 
its applicability to all clinical settings and private practice may be 
difficult because of the exorbitant cost involved. A cost effective way to 
deal with the same situation is using intracanal medicaments. The use of 
an intracanal medicament helps in the elimination of bacteria that remains 
even after cleaning and shaping, there by providing an environment 
conducive for periapical tissue repair.16 
 63 
 Many medicaments were used as intracanal dressings in the past 
decades and according to their chemical basis, generally fall into the 
following categories: phenolic derivatives (eugenol, camphorated para-
monochlorophenol, camphorated phenol, metacresyl acetate, beechwood 
creosote), aldehydes (formocresol), halides (iodine–potassium iodide), 
calcium hydroxide, antibiotics, and various combinations. The most 
popular intracanal medicament in use currently is calcium hydroxide. 
However, various studies confirmed the resistance of E. faecalis to 
Calcium hydroxide. Various newer medicaments are also tried nowadays, 
as Bioactive glass and Octanidine. 2% CHX has been found to be highly 
active against E. faecalis.21, 44 CHX seems to act by adsorbing on to the 
cell wall of microorganisms and causing the leakage of intracellular 
components. It also has the property of substantivity.5, 37, 50, 52, 96  
 There has been a worldwide move towards the use of traditional 
medicines due to concerns over the more invasive, expensive and 
potentially toxic mainstream practices (WHO, 2002). Numerous studies 
have identified compounds within herbals that are effective antibiotics 
(Basile et al., 2000; Cowan, 1999). Traditional healing systems around 
the world that utilize herbal remedies are an important resource for the 
discovery of new antibiotics (Okpekon et al., 2004). Certain traditional 
remedies have already been reported to be effective against drug-resistant 
bacteria (Kone et al., 2004; Sato et al., 2000). These facts provoked us to 
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test an herbal preparation as an intracanal medicament, to find the activity 
against E. faecalis.  
 Triphala (a Siddha Herbal Formulation) and T. chebula were 
selected because of their known broad spectrum of antimicrobial activity. 
Triphala has been used extensively as a drug against a number of diseases 
(Awasthi and Nath, 1986; Reddy et al., 1990). Triphala is prescribed for 
various symptoms of infections, fatigue, assimilation and infectious 
diseases such as tuberculosis, pneumonia, AIDS (El-Mekkawey and 
Merelhy, 1995), periodontal diseases (Abraham et al., 2005) and has been 
reported to reduce considerably the damage due to oxidative stresses in 
experimental rats (Srikumar et al., 2006). Because of its tremendous 
potential, it is called the ‘Wonder Drug’.  
 T. chebula is reported to have antioxidant and free radical 
scavenging activities. It is effective against cancer cells80 and various 
microorganisms.56, 87 It is also useful as an anti-caries agent87, in dermal 
wound healing41, improving gastrointestinal motility, anaphylactic 
shock84 and in diabetes mellitus.79 So, it is called the ‘King of 
Medicines’.14 
 Alcoholic extracts of Triphala and T. chebula were selected as they 
showed high antibacterial activity compared with aqueous extracts, which 
might possibly be due to the lesser solubility of the active components in  
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aqueous solutions.87 DMSO was used as a solvent, as it does not have any 
antibacterial action on its own,56 which had been proved in previous 
studies and in this study by using it as a control. It is a highly polar 
organic reagent that has exceptional solvent properties for organic and 
inorganic chemicals. Thus, it helps in complete dissolution of the 
extracts.  
 Assessment of MIC was done to find the concentration of the 
extracts needed to show antibacterial activity. In this study, MIC was 
found to be 20mg / ml for Triphala and 30mg / ml for T. chebula. But in a 
previous study, the MIC for Triphala and T. chebula against E. faecalis 
were found to be as low as 0.1 µg / ml.87 This could be because of the 
effects of geographic variations on the phytochemical concentratation.42 
 The agar diffusion method has been widely used to test the 
antimicrobial activity of dental materials and medicaments.31 So, this was 
used to compare the zone of inhibition produced by the antimicrobial 
agents used in this study. Among them, Triphala & T. chebula showed 
highly significant difference and proved to be superior when compared 
with CHX & Amoxicillin. CHX showed superior antimicrobial action 
when compared with Amoxicillin. There was no statistically significant 
difference between Triphala & T. chebula. This revealed that, the extracts 
have superior antimicrobial activity against E. faecalis. The advantage of 
this method is that, it allows direct comparison of the materials against 
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the organisms, indicating which material has the potential to eliminate 
bacteria in the local microenvironment of the root canal system. 
However, the limitation of this method is that the result not only depends 
on the toxicity of the material for the particular organism, but also is 
influenced by the ability of the material to diffuse across the medium.74 
Further, the materials which show antimicrobial activity in culture plates 
may not have the same when used as an intracanal medicament, because 
of the intricacies of the canal system and inherent ability of the dentin to 
have a negative impact on medication performance.59  
 Generally, bacteria are present in a state of biofilm in the root 
canals. Estimate of 1000 to 1500 times greater resistance for biofilm 
grown cells than planktonically grown cells have been suggested. This 
may turn the same medicament which showed activity against planktonic 
bacteria to be inactive in clinical scenario. The nature of the substrate 
may also influence the nature of the biofilm. So, we opted to test the 
activity of the herbal extracts against the biofilm produced in teeth 
samples which may also help in assessing the activity in different dentin 
penetration depths.  
 The experimental model used in this study was adapted from that 
established by Ørstavik and Haapasalo for infection and disinfection of 
dentinal tubules. The model was adapted for extracted human teeth rather 
than bovine incisors. This modification was considered appropriate 
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because of the marked difference in diameter between the canals of 
bovine and human teeth and thus in the volume of medicament that can 
be placed in these canals. Propylene glycol was used as a vehicle for the 
herbal extracts, as it can deliver the medicaments rapidly and more 
effectively in the root canal system and within dentinal tubules.18  
 In this study all the medicaments tested showed significant 
antimicrobial action on E. faecalis when compared with the control 
group, when assessed by the colony count and OD values. When CFU/ml 
were considered, Triphala and T. chebula showed 100% inhibition at both 
200 µm and 400 µm in all the samples. 2% CHX showed 100% inhibition 
in all the samples at 200 µm depth and 50% of the samples showed 100% 
inhibition at 400 µm. There was statistical significance between the test 
groups and the positive control group. But, there was no statistically 
significant difference between CHX, Triphala and T. chebula.  
 When OD values were considered, all the groups showed 
significant difference with the positive control group. There was no 
significant difference between CHX, Triphala and T. chebula at 200 µm 
depth. But, there was statistically significant difference between the 
herbal extracts and CHX at 400 µm depth. Even though there is no 
statistically significant difference between test groups when CFU/ml were 
considered, complete inhibition of the organism at both the depths in all 
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the Triphala and T. chebula treated specimens may have some clinical 
significance.  
 Tannic acid represents the major constituent of the ripe fruit of T. 
chebula and is present in a concentration of 20–40% (Chopra and Handa, 
1958). The chief constituents of tannin are chebulic acid, chebulagic acid, 
corilagin and gallic acid. Tannin of Terminalia chebula are of pyrogallol 
(hydrolyzable) type. A group of researchers found 14 components of 
hydrolyzable tannins (gallic acid, chebulic acid, punicalagin, chebulanin, 
corilagin, neochebulinic acid, ellagic acid, chebulegic acid, chebulinic 
acid, 1,2,3,4,6- penta-O-galloyl-H-D-glucose, 1,6,-di-O-galloyl-D-
glucose, casuarinin, 3,4,6-tri-O-galloyl-D- glucose, terchebulin) from 
Terminalia chebula fruits.14 The fruits also contain a variety of 
carbohydrates, glucose and sorbitol being the major ones. The pericarp of 
the fruit contains anthraquinone glycosides, saponins, anthrones and 
anthranols.  
Model structure of Tannins 
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 The dried fruits of T. bellerica contain about 20% tannins of both 
condensed and hydrolysable type. Other constituents identified in the fruit 
include lipids, b-sitosterol, saponins, gallic and ellagic acids and their 
derivatives, glycosides and various carbohydrates.  
 Phyllanthus emblica also contains hydrolysable tannins 
(emblicanin A, emblicanin b, punigluconin 12% and pedunculagin). 
 The total tannin content of the extracts used in this study was found 
to be 42.25% w/w for Triphala and 42.80% w/w for T. chebula. The 
antibacterial activities of tannins are well documented. Tannins inhibited 
the growth of many fungi, yeasts, bacteria and viruses. Tannins in these 
fruits thus serve as natural defense mechanisms against microbial 
infections.14  
 One of their molecular actions is to complex with proteins through 
so-called nonspecific forces such as hydrogen bonding and hydrophobic 
effects, as well as by covalent bond formation. Thus, their mode of 
antimicrobial action, may be related to their ability to inactivate microbial 
adhesins, enzymes, cell envelope transport proteins, etc.56 Because of this 
the antibacterial activity could be attributed to either inhibiting the cell 
division or to damaging the cell walls of bacteria.87 They also complex 
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with polysaccharide. The antimicrobial significance of this particular 
activity was not explored earlier.56 We speculate that this property of 
tannins may aid in complexing with glycocalyx (Extracellular polymeric 
substance which contains polysaccharides and surrounds the 
microcolonies and anchor the bacterial cell to the substrate) and disrupt 
biofilm, which may greatly aid in enhancing the antimicrobial action over 
biofilm. From the literature it has been noted that T. chebula exhibited 
significant hepatoprotective, cardioprotective, 
antimutagenic/anticarcinogenic,80 cytoprotective, radioprotective, 
antioxidant63 and adaptogenic76, 84 effects indicating that it is a safe 
substance to be used as a drug.14  
 Literature review regarding safety of these herbal extracts stated 
that Crude alcoholic extracts of T. chebula, T. bellerica and P. Emblica 
were found to lack cellular toxicity in an assay using fresh sheep 
erythrocytes.3 T. chebuala does not exert any cytotoxic effect in allium 
model. T. chebula by itself had no genotoxic effect both in VITOTOX 
test and Ames assay.14 The aqueous extract of T. bellerica fruit was found 
to be non-toxic when administered orally to mice, whereas the LD50 of 
the alcoholic extract was equivalent to 4.25g crude drug per kilo body 
weight. A water soluble fraction of T. bellerica showed no signs of 
toxicity in mice at oral doses up to 3.2g/kg bodyweight. These facts 
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reveal that, it can be safely used as intracanal medicament, even in invivo 
settings.  
 These extracts also have antimicrobial action on various other 
bacteria (gram positive and gram negative), fungi and viruses,20, 87 which 
may help in canal disinfection, even in polymicrobial infection, invivo. 
These extracts also have anti-inflammatory property75 and wound healing 
potential.51 So, they may have a positive influence on minimizing post-
operative pain and favour periapical healing, which can be areas of 
interest for future research.  
 Further exploration should be done on these herbs, which can 
enable us to utilize the gift of divine nature. 
 
 
 
  
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
        TRIPHALA        T.  CHEBULA    CHX              AMOXICILLIN         DMSO  
Zone Of Inhibition (mm)
45.33
25
19.67
0.001
48
0
10
20
30
40
50
TRIPHALA T.CHEBILA CHX AMOXYCILLIN DMSO
M
EA
N 
  
Comparison of OD values between Groups at                         
200 µm & 400 µm 
 
 
 
 
 
 
 
 
 
 
 
Comparison of CFU/ml between Groups at 200 µm & 400 µm 
 
 
 
 
0 
0.1 
0.2 
0.3 
0.4 
0.5 
GROUP - I GROUP - II GROUP - III GROUP - IV GROUP - V
M
E
A
N  
OD - 200 µm OD- 400 µm
 
0 
40 
80 
120 
160 
200 
GROUP - I GROUP - II GROUP - III GROUP - IV GROUP - V
M
E
A
N 
CFU - 200 µm CFU - 400 µm
 50 
RESULTS & STATISTICAL ANALYSIS 
I. The values of zone of inhibition produced are presented in Table 1.1. 
 
Table 1.1 - Zone of Inhibition (mm)   
Triphala 45 46 45 
T. chebula 48 49 47 
CHX 25 23 27 
Amoxicillin 20 18 21 
DMSO 0 0 0 
     
 The data were analysed by Oneway Anova followed by Tukey – HSD 
(Post-Hoc) multiple comparison test and Kruskal-Wallis test.  
Table 1.2 - ANOVA 
  Mean SD 
Triphala 45.33 0.577 
T. chebula 48 1 
CHX 25 2 
Amoxicillin 19.67 1.528 
DMSO 0 0 
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Table 1.3 - TUKEY – HSD MULTIPLE COMPARISONS 
Comparisons Mean Difference p value 
Triphala vs T. chebula -2.667 > 0.05 
Triphala vs CHX 20.333 < 0.001 
Triphala vs AMOX 25.667 < 0.001 
Triphala vs DMSO 45.333 < 0.001 
T. chebula vs CHX 23.000 < 0.001 
T. chebula vs AMOX 28.333 < 0.001 
T. chebula vs DMSO 48.000 < 0.001 
CHX vs AMOX 5.333 < 0.01 
CHX vs DMSO 25.000 < 0.001 
AMOX vs DMSO 19.667 < 0.001 
 
Table 1.4 - KURSKAL – WALLIS TEST 
  Mean Rank p value 
Triphala 11 
T. chebula 14 
CHX 8 
Amoxicillin 5 
DMSO 2 
< 0.01 
 
 
INFERENCE 
• All the antimicrobial agents showed high statistically 
significant difference (p < 0.001) when compared with DMSO. 
• There was no statistically significant difference between 
Triphala and T. chebula (p > 0.05) 
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• Triphala and T. chebula showed high significant difference     
(p < 0.001) when compared with Amoxicillin and CHX. 
• CHX showed significant difference (p < 0.01) when compared 
with Amoxicillin. 
 
II. The OD Values measured for all the groups at 200 µm & 400 µm 
are presented in the Table 2.1 & 2.2. 
Table 2.1 – OD Values (200 µm) 
Group 1 0.474 0.482 0.486 0.461 0.419 0.456 
Group 2 0.003 0 0.001 0.002 0 0 
Group 3 0 0.002 0.002 0.001 0 0.001 
Group 4 0 0.001 0.002 0.001 0.001 0.003 
Group 5 0.001 0 0.002 0.001  - -  
 
Table 2.2 – OD Values (400 µm) 
Group 1 0.468 0.462 0.473 0.458 0.42 0.459 
Group 2 0 0.002 0 0.001 0.003 0 
Group 3 0.002 0 0.001 0 0.001 0.001 
Group 4 0.001 0.028 0.011 0.026 0.042 0.018 
Group 5 0 0.001 0 0.002 -  - 
 
 The data were statistically analysed using Oneway Anova followed by 
Tukey – HSD (Post-Hoc) multiple comparison test and Kruskal-Wallis 
test was done for non-parametric data. 
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Table 2.3 – ANOVA (OD Values) 
200 µm 400 µm 
Groups Mean SD Mean SD 
Group 1 0.46300 0.024495 0.45667 0.018843 
Group 2 0.00100 0.001265 0.00100 0.001265 
Group 3 0.00100 0.000894 0.00083 0.000753 
Group 4 0.00133 0.001033 0.02100 0.014311 
Group 5 0.00100 0.000816 0.00075 0.000957 
 
 
Table 2.4 - TUKEY – HSD MULTIPLE COMPARISONS  
200 µm 400 µm 
Goups 
Comparison 
Mean 
Difference p value 
Mean 
Difference p value 
G1 vs G2 0.462000 < 0.001 0.455667 < 0.001 
G1 vs G3 0.462000 < 0.001 0.455833 < 0.001 
G1 vs G4 0.461667 < 0.001 0.435667 < 0.001 
G1 vs G5 0.462000 < 0.001 0.455917 < 0.001 
G2 vs G3 0.000000 > 0.05 0.000167 > 0.05 
G2 vs G4 -0.000333 > 0.05 -0.020000 < 0.05 
G2 vs G5 0.000000 > 0.05 0.000250 > 0.05 
G3 vs G4 -0.000333 > 0.05 -0.020167 < 0.05 
G3 vs G5 0.000000 > 0.05 0.000083 > 0.05 
G4 vs G5 0.000333 > 0.05 0.020250 > 0.05 
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Table 2.5 – KRUSKAL – WALLIS TEST (OD Values) 
200 µm 400 µm 
Goups 
Mean rank p value Mean rank p value 
Group 1 25.50 25.50 
Group 2 10.50 9.08 
Group 3 11.17 9.08 
Group 4 13.00 18.42 
Group 5 11.25 
< 0.01 
8.38 
< 0.001 
 
INFERENCE 
At 200µm: 
• Group 1 showed highly significant difference (p < 0.001) when 
compared with all other groups.  
• Group 2, 3, 4 & 5 did not show any significant difference (p > 0.05) 
among them at 200µm. 
 
At 400µm: 
• Group 1 showed highly significant difference (p < 0.001) when 
compared with all other groups. 
• Group 2 & 3 did not show any statistically significant difference       
(p > 0.05) between them and when compared with Group 5. 
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• Group 2 & 3 had statistically significant difference (p < 0.05) when 
compared with Group 4. 
 
 
III. The CFU / ml values measured for all the groups at 200 µm & 
400 µm are presented in the Table 3.1 & 3.2. 
Table 3.1 – CFU / ml Values (200 µm) 
Group 1 
(x 109) 156 168 170 148 142 154 
Group 2 0 0 0 0 0 0 
Group 3 0 0 0 0 0 0 
Group 4 0 0 0 0 0 0 
Group 5 0 0 0 0 -  - 
 
 
Table 3.2 – CFU / ml Values (400 µm) 
Group 1 
(x 109)  148 152 164 152 150 160 
Group 2 0 0 0 0 0 0 
Group 3 0 0 0 0 0 0 
Group 4 0 10 0 10 20 0 
Group 5 0 0 0 0 -  - 
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Table 3.3 - ANOVA (CFU / ml) 
200 µm 400 µm 
Groups Mean SD Mean SD 
Group 1 
(x 109) 156.33 10.985 154.33 6.250 
Group 2 0.00 0.000 0.00 0.000 
Group 3 0.00 0.000 0.00 0.000 
Group 4 0.00 0.000 6.67 8.165 
Group 5 0.00 0.000 0.00 0.000 
 
Table 3.4 - TUKEY – HSD MULTIPLE COMPARISONS  
200 µm 400 µm 
Groups 
Comparison Mean 
Difference p value 
Mean 
Difference p value 
G1 vs G2  
156.333  
x 109 < 0.001 
154.333  
x 109 < 0.001 
G1 vs G3 
156.333  
x 109 < 0.001 
154.333 
x 109 < 0.001 
G1 vs G4 
156.333 
x 109 < 0.001 
147.667 
x 109 < 0.001 
G1 vs G5 
156.333 
x 109 < 0.001 
154.333 
x 109 < 0.001 
G2 vs G3 0.000 > 0.05 0.000 > 0.05 
G2 vs G4 0.000 > 0.05 -6.667 > 0.05 
G2 vs G5 0.000 > 0.05 0.000 > 0.05 
G3 vs G4 0.000 > 0.05 -6.667 > 0.05 
G3 vs G5 0.000 > 0.05 0.000 > 0.05 
G4 vs G5 0.000 > 0.05 6.667 > 0.05 
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Table 3.5 – KRUSKAL – WALLIS TEST (CFU / ml Values) 
200 µm 400 µm 
Groups 
Mean rank p value Mean rank p value 
Group 1 25.50 25.50 
Group 2 11.50 10.00 
Group 3 11.50 10.00 
Group 4 11.50 15.50 
Group 5 11.50 
< 0.001 
10.00 
< 0.001 
 
INFERENCE  
At 200 µm & 400 µm: 
• Group 1 showed highly significant difference (p < 0.001) when 
compared with all the other groups. 
• Group 2, 3, 4 & 5 didn’t have any statistical significance (p > 0.05) 
among them. 
 
IV. OD values and CFU / ml at 200 µm & 400 µm for each individual 
group were compared using independent sample test (Student t-test). 
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Table 4.1 – Independent Samples Test (Student t-Test) 
CFU / ml OD 
Groups Mean SD p value Mean SD 
p 
value 
200µm 156.33 x 109 
10.98484  
x 109 
0.46300 
x 109 
0.0245  
x 109 Group 1 
400µm 154.33 x 109 
6.25033 
x 109 > 0.05 
0.45670 
x 109 
0.0188 
x 109 > 0.05 
200µm 0 0 0.00100 0.0013 Group 2 
400µm 0 0 > 0.05 0.00100 0.0013 > 0.05 
200µm 0 0 0.00100 0.0009 Group 3 
400µm 0 0 > 0.05 0.00083 0.0008 > 0.05 
200µm 0 0 0.00133 0.0013 Group 4 
400µm 6.6667 8.16497 > 0.05 0.02100 0.0143 < 0.05 
200µm 0 0 0.00100 0.0008 Group 5 
400µm 0 0 > 0.05 0.00075 0.001 > 0.05 
 
 
 
Table 4.2 – Mann-Whitney Test 
  p value 
CFU OD 
200 & 
400 
200 & 
400 Group 4 
> 0.05 < 0.05 
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INFERENCE 
• There was no statistically significant difference (p > 0.05) between 
200µm & 400µm values, when assessed by OD or CFU / ml in Group 
1, 2, 3    & 5. 
• In Group 4, there was no statistical significance (p > 0.05) between 
the 200 µm & 400 µm values, when assessed by CFU / ml. But, there 
was statistically significant difference (p < 0.05) when OD values 
were analysed.  
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INFERENCE OF THE STUDY 
I Zone of Inhibition: 
• All the antimicrobial agents showed high statistically 
significant difference (p < 0.001) when compared with DMSO. 
• There was no statistically significant difference between 
Triphala and T. chebula (p > 0.05) 
• Triphala and T. chebula showed high significant difference     
(p < 0.001) when compared with Amoxicillin and CHX. 
• CHX showed significant difference (p < 0.01) when compared 
with Amoxicillin. 
II OD Values: 
• Group 1 showed highly significant difference (p < 0.001) when 
compared with all other groups at 200 & 400 µm.  
• Group 2, 3, 4 & 5 did not show any significant difference (p > 0.05) 
among them at 200µm. 
• Group 2 & 3 did not show any statistically significant difference       
(p > 0.05) between them and when compared with Group 5. 
• Group 2 & 3 had statistically significant difference (p < 0.05) when 
compared with Group 4. 
 61 
• In groups 1, 2, 3 & 5 there was no statistically significant difference 
(p > 0.05) between 200 & 400 µm values, within a group, when 
assessed by OD values. 
• There was statistically significant difference (p < 0.05) between 200 
& 400 µm values in Group 4. 
 
III CFU/ml Values: 
• Group 1 showed highly significant difference (p < 0.001) when 
compared with all the other groups. 
• Group 2, 3, 4 & 5 didn’t have any statistical significance (p > 0.05) 
among them. 
• In all the groups there was no statistically significant difference 
between 200 µm & 400 µm values, within a group, when assessed by 
CFU/ml. 
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DISCUSSION 
 
 Microorganisms play a fundamental role in the etiology of pulp 
and periapical diseases. Their control and elimination are important 
during endodontic treatment.47 E. faecalis is probably the species that can 
best adapt to and tolerate the ecologically demanding conditions in the 
filled root canals. It is resistant to various antimicrobials. It is considered 
as a ‘star’ in post-treatment disease.40 Because of this the development of 
effective therapeutic modalities against E. faecalis is desirable. Hence     
E. faecalis was chosen for the inoculum in this study. In addition,            
E. faecalis is relatively easy to culture and it has been used successfully in 
most studies with the original model.5, 37, 50, 52, 66 
 Various modalities are attempted to eliminate residual bacteria 
from the root canal, which includes high end technologies as with 
LASERS, PAD and ANILAD. Even though these show promising results, 
its applicability to all clinical settings and private practice may be 
difficult because of the exorbitant cost involved. A cost effective way to 
deal with the same situation is using intracanal medicaments. The use of 
an intracanal medicament helps in the elimination of bacteria that remains 
even after cleaning and shaping, there by providing an environment 
conducive for periapical tissue repair.16 
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 Many medicaments were used as intracanal dressings in the past 
decades and according to their chemical basis, generally fall into the 
following categories: phenolic derivatives (eugenol, camphorated para-
monochlorophenol, camphorated phenol, metacresyl acetate, beechwood 
creosote), aldehydes (formocresol), halides (iodine–potassium iodide), 
calcium hydroxide, antibiotics, and various combinations. The most 
popular intracanal medicament in use currently is calcium hydroxide. 
However, various studies confirmed the resistance of E. faecalis to 
Calcium hydroxide. Various newer medicaments are also tried nowadays, 
as Bioactive glass and Octanidine. 2% CHX has been found to be highly 
active against E. faecalis.21, 44 CHX seems to act by adsorbing on to the 
cell wall of microorganisms and causing the leakage of intracellular 
components. It also has the property of substantivity.5, 37, 50, 52, 96  
 There has been a worldwide move towards the use of traditional 
medicines due to concerns over the more invasive, expensive and 
potentially toxic mainstream practices (WHO, 2002). Numerous studies 
have identified compounds within herbals that are effective antibiotics 
(Basile et al., 2000; Cowan, 1999). Traditional healing systems around 
the world that utilize herbal remedies are an important resource for the 
discovery of new antibiotics (Okpekon et al., 2004). Certain traditional 
remedies have already been reported to be effective against drug-resistant 
bacteria (Kone et al., 2004; Sato et al., 2000). These facts provoked us to 
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test an herbal preparation as an intracanal medicament, to find the activity 
against E. faecalis.  
 Triphala (a Siddha Herbal Formulation) and T. chebula were 
selected because of their known broad spectrum of antimicrobial activity. 
Triphala has been used extensively as a drug against a number of diseases 
(Awasthi and Nath, 1986; Reddy et al., 1990). Triphala is prescribed for 
various symptoms of infections, fatigue, assimilation and infectious 
diseases such as tuberculosis, pneumonia, AIDS (El-Mekkawey and 
Merelhy, 1995), periodontal diseases (Abraham et al., 2005) and has been 
reported to reduce considerably the damage due to oxidative stresses in 
experimental rats (Srikumar et al., 2006). Because of its tremendous 
potential, it is called the ‘Wonder Drug’.  
 T. chebula is reported to have antioxidant and free radical 
scavenging activities. It is effective against cancer cells80 and various 
microorganisms.56, 87 It is also useful as an anti-caries agent87, in dermal 
wound healing41, improving gastrointestinal motility, anaphylactic 
shock84 and in diabetes mellitus.79 So, it is called the ‘King of 
Medicines’.14 
 Alcoholic extracts of Triphala and T. chebula were selected as they 
showed high antibacterial activity compared with aqueous extracts, which 
might possibly be due to the lesser solubility of the active components in  
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aqueous solutions.87 DMSO was used as a solvent, as it does not have any 
antibacterial action on its own,56 which had been proved in previous 
studies and in this study by using it as a control. It is a highly polar 
organic reagent that has exceptional solvent properties for organic and 
inorganic chemicals. Thus, it helps in complete dissolution of the 
extracts.  
 Assessment of MIC was done to find the concentration of the 
extracts needed to show antibacterial activity. In this study, MIC was 
found to be 20mg / ml for Triphala and 30mg / ml for T. chebula. But in a 
previous study, the MIC for Triphala and T. chebula against E. faecalis 
were found to be as low as 0.1 µg / ml.87 This could be because of the 
effects of geographic variations on the phytochemical concentratation.42 
 The agar diffusion method has been widely used to test the 
antimicrobial activity of dental materials and medicaments.31 So, this was 
used to compare the zone of inhibition produced by the antimicrobial 
agents used in this study. Among them, Triphala & T. chebula showed 
highly significant difference and proved to be superior when compared 
with CHX & Amoxicillin. CHX showed superior antimicrobial action 
when compared with Amoxicillin. There was no statistically significant 
difference between Triphala & T. chebula. This revealed that, the extracts 
have superior antimicrobial activity against E. faecalis. The advantage of 
this method is that, it allows direct comparison of the materials against 
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the organisms, indicating which material has the potential to eliminate 
bacteria in the local microenvironment of the root canal system. 
However, the limitation of this method is that the result not only depends 
on the toxicity of the material for the particular organism, but also is 
influenced by the ability of the material to diffuse across the medium.74 
Further, the materials which show antimicrobial activity in culture plates 
may not have the same when used as an intracanal medicament, because 
of the intricacies of the canal system and inherent ability of the dentin to 
have a negative impact on medication performance.59  
 Generally, bacteria are present in a state of biofilm in the root 
canals. Estimate of 1000 to 1500 times greater resistance for biofilm 
grown cells than planktonically grown cells have been suggested. This 
may turn the same medicament which showed activity against planktonic 
bacteria to be inactive in clinical scenario. The nature of the substrate 
may also influence the nature of the biofilm. So, we opted to test the 
activity of the herbal extracts against the biofilm produced in teeth 
samples which may also help in assessing the activity in different dentin 
penetration depths.  
 The experimental model used in this study was adapted from that 
established by Ørstavik and Haapasalo for infection and disinfection of 
dentinal tubules. The model was adapted for extracted human teeth rather 
than bovine incisors. This modification was considered appropriate 
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because of the marked difference in diameter between the canals of 
bovine and human teeth and thus in the volume of medicament that can 
be placed in these canals. Propylene glycol was used as a vehicle for the 
herbal extracts, as it can deliver the medicaments rapidly and more 
effectively in the root canal system and within dentinal tubules.18  
 In this study all the medicaments tested showed significant 
antimicrobial action on E. faecalis when compared with the control 
group, when assessed by the colony count and OD values. When CFU/ml 
were considered, Triphala and T. chebula showed 100% inhibition at both 
200 µm and 400 µm in all the samples. 2% CHX showed 100% inhibition 
in all the samples at 200 µm depth and 50% of the samples showed 100% 
inhibition at 400 µm. There was statistical significance between the test 
groups and the positive control group. But, there was no statistically 
significant difference between CHX, Triphala and T. chebula.  
 When OD values were considered, all the groups showed 
significant difference with the positive control group. There was no 
significant difference between CHX, Triphala and T. chebula at 200 µm 
depth. But, there was statistically significant difference between the 
herbal extracts and CHX at 400 µm depth. Even though there is no 
statistically significant difference between test groups when CFU/ml were 
considered, complete inhibition of the organism at both the depths in all 
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the Triphala and T. chebula treated specimens may have some clinical 
significance.  
 Tannic acid represents the major constituent of the ripe fruit of T. 
chebula and is present in a concentration of 20–40% (Chopra and Handa, 
1958). The chief constituents of tannin are chebulic acid, chebulagic acid, 
corilagin and gallic acid. Tannin of Terminalia chebula are of pyrogallol 
(hydrolyzable) type. A group of researchers found 14 components of 
hydrolyzable tannins (gallic acid, chebulic acid, punicalagin, chebulanin, 
corilagin, neochebulinic acid, ellagic acid, chebulegic acid, chebulinic 
acid, 1,2,3,4,6- penta-O-galloyl-H-D-glucose, 1,6,-di-O-galloyl-D-
glucose, casuarinin, 3,4,6-tri-O-galloyl-D- glucose, terchebulin) from 
Terminalia chebula fruits.14 The fruits also contain a variety of 
carbohydrates, glucose and sorbitol being the major ones. The pericarp of 
the fruit contains anthraquinone glycosides, saponins, anthrones and 
anthranols.  
Model structure of Tannins 
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 The dried fruits of T. bellerica contain about 20% tannins of both 
condensed and hydrolysable type. Other constituents identified in the fruit 
include lipids, b-sitosterol, saponins, gallic and ellagic acids and their 
derivatives, glycosides and various carbohydrates.  
 Phyllanthus emblica also contains hydrolysable tannins 
(emblicanin A, emblicanin b, punigluconin 12% and pedunculagin). 
 The total tannin content of the extracts used in this study was found 
to be 42.25% w/w for Triphala and 42.80% w/w for T. chebula. The 
antibacterial activities of tannins are well documented. Tannins inhibited 
the growth of many fungi, yeasts, bacteria and viruses. Tannins in these 
fruits thus serve as natural defense mechanisms against microbial 
infections.14  
 One of their molecular actions is to complex with proteins through 
so-called nonspecific forces such as hydrogen bonding and hydrophobic 
effects, as well as by covalent bond formation. Thus, their mode of 
antimicrobial action, may be related to their ability to inactivate microbial 
adhesins, enzymes, cell envelope transport proteins, etc.56 Because of this 
the antibacterial activity could be attributed to either inhibiting the cell 
division or to damaging the cell walls of bacteria.87 They also complex 
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with polysaccharide. The antimicrobial significance of this particular 
activity was not explored earlier.56 We speculate that this property of 
tannins may aid in complexing with glycocalyx (Extracellular polymeric 
substance which contains polysaccharides and surrounds the 
microcolonies and anchor the bacterial cell to the substrate) and disrupt 
biofilm, which may greatly aid in enhancing the antimicrobial action over 
biofilm. From the literature it has been noted that T. chebula exhibited 
significant hepatoprotective, cardioprotective, 
antimutagenic/anticarcinogenic,80 cytoprotective, radioprotective, 
antioxidant63 and adaptogenic76, 84 effects indicating that it is a safe 
substance to be used as a drug.14  
 Literature review regarding safety of these herbal extracts stated 
that Crude alcoholic extracts of T. chebula, T. bellerica and P. Emblica 
were found to lack cellular toxicity in an assay using fresh sheep 
erythrocytes.3 T. chebuala does not exert any cytotoxic effect in allium 
model. T. chebula by itself had no genotoxic effect both in VITOTOX 
test and Ames assay.14 The aqueous extract of T. bellerica fruit was found 
to be non-toxic when administered orally to mice, whereas the LD50 of 
the alcoholic extract was equivalent to 4.25g crude drug per kilo body 
weight. A water soluble fraction of T. bellerica showed no signs of 
toxicity in mice at oral doses up to 3.2g/kg bodyweight. These facts 
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reveal that, it can be safely used as intracanal medicament, even in invivo 
settings.  
 These extracts also have antimicrobial action on various other 
bacteria (gram positive and gram negative), fungi and viruses,20, 87 which 
may help in canal disinfection, even in polymicrobial infection, invivo. 
These extracts also have anti-inflammatory property75 and wound healing 
potential.51 So, they may have a positive influence on minimizing post-
operative pain and favour periapical healing, which can be areas of 
interest for future research.  
 Further exploration should be done on these herbs, which can 
enable us to utilize the gift of divine nature. 
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SUMMARY 
 Endodontic treatment is targeted towards reduction and elimination of 
microorganisms from the root canal system. Intracanal medicaments can aid 
in achieving this objective. This study evaluates the antimicrobial activity of 
Triphala & T. chebula against E. faecalis, in comparison with 2% CHX. 
Minimal inhibitory concentration of the alcoholic extracts of Triphala & T. 
chebula was found using agar-dilution method. Agar diffusion method was 
used to compare the zone of inhibition produced by the herbal extracts & 
CHX. All the three showed significant antimicrobial activity when compared 
with the control groups. The herbal extracts showed significant difference 
when compared with CHX.  
 Activity on biofilms formed in teeth samples were studied using a 
modification of the model proposed by Haapasalo & Orstavik. The dentin 
blocks were infected with E. faecalis for 21 days, then they were divided 
into 4 groups based on the medication given, as  
  Group I – Saline (Infected dentine blocks),  
  Group II – Triphala,  
  Group III – T. chebula & 
  Group IV – CHX. 
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 The medicaments were maintained for 7 days. Uninfected dentine 
samples served as negative control in Group V. At the end of 1 week, 
antimicrobial efficiency was assessed at the depths of 200µm & 400µm, by 
colony count (CFU / ml) & optical density (OD) values. All the 3 
medicaments showed statistically significant antimicrobial activity. 
Assessment of the antimicrobial activity using OD values did not show any 
statistically significant difference among the test groups at 200µm. But there 
was statistically significant difference between the herbal extracts and CHX 
at 400µm.  
 On microbial culturing, Triphala & T. chebula showed 100% 
inhibition of growth of bacteria in all the samples. CHX showed 100% 
inhibition in all the samples at 200µm and in 50% of the samples at 400µm. 
Assessment of the colony count (CFU / ml) showed significant antimicrobial 
activity for all of the medicaments. The difference shown between the 
extracts & CHX in the colony count was not statistically significant. But 
complete inhibition shown by the herbal extracts in all the samples may have 
some clinical significance. The results showed the potential of Triphala and 
T. chebula to be used as intracanal medicament. 
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CONCLUSION 
 Results of this study indicate that E. faecalis biofilm present in the 
root canal system can be eliminated or reduced with intracanal medicaments. 
The herbal extracts of Triphala, T. chebula have the potential to be used as 
intracanal medicaments, as the already established 2% of CHX. They also 
have antimicrobial action on the E. faecalis biofilm penetrated within the 
dentinal tubules. The herbal extracts may have superior antimicrobial 
activity even at deeper dentine depths. Thus, this study opens a new avenue 
of trying herbal extracts as intracanal medicaments to eliminate the 
microorganism in the root canal system and aid in long term success in 
endodontics. 
 75 
BIBLIOGRAPHY 
 
1. Abbas ali Khademi; Zahed Mohammadi and Asgar Havaee. 
Evaluation of the antibacterial substantivity of several intra-canal 
agents. Aust Endod J 2006; 32: 112–115. 
 
2. Agarwal K C. Antibiotic sensitivity test by disc diffusion method, 
Standardization & Interpretation. Ind. J. Path & Bact., 1974, 17(3), 
149. 
 
3. Ahmad, Mehmood, Mohammad. Screening of some Indian 
medicinal plants for their antimicrobial properties. J. 
Ethnopharmacol. 1998, 62(2) : 183-93. 
 
4. Ajitha P,  Rao CVN,  Lakshminarayanan L. Time dependent 
inhibitory effect of dentin on various calcium hydroxide 
medicaments - An in vitro study. Endodontology, 2003; 15:7-11. 
 
5. Basrani B, Santos JM, Tja¨derhane L, Grad H, Gorduysus O, 
Huang J, et al. Substantive antimicrobial activity in chlorhexidine-
treated human root dentin. Oral Surg Oral Med Oral Pathol Oral 
Radiol Endod 2002;94:240-5. 
 
6. Bettina Basrani, Leo Tja¨derhane, J. Miguel Santos, Elizeu Pascon, 
Helen Grad, Herenia P. Lawrence, and Shimon Friedman. Efficacy 
of chlorhexidine- and calcium hydroxide–containing medicaments 
against Enterococcus faecalis in vitro. Oral Surg Oral Med Oral 
Pathol Oral Radiol Endod 2003;96:618-24. 
 
7. Bettina Basrani, Miguel Santos, Leo Tja¨derhane, Helen Grad, 
Omer Gorduysus, Junfu Huang, Herenia P. Lawrence, and Shimon 
Friedman. Substantive antimicrobial activity in chlorhexidine-
treated human root dentin. Oral Surg Oral Med Oral Pathol Oral 
Radiol Endod 2002;94:240-5 
 
8. Brenda Paula Figueiredo de Almeida Gomes, Morgana Eli Vianna, 
Neylla Teixeira Sena, Alexandre Augusto Zaia, Caio Cezar Randi 
Ferraz, and Francisco José de Souza Filho, Piracicaba. In vitro 
evaluation of the antimicrobial activity of calcium hydroxide 
combined with chlorhexidine gel used as intracanal medicament. 
Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2006;  
102:544-50. 
 76 
 
9. C. M. Sedgley, S. L. Lennan & O. K. Appelbe. Survival of 
Enterococcus faecalis in root canals ex vivo. International 
Endodontic Journal, 2005, 38(10), 735–742. 
 
10. C. Sathorn, Parashos & Messer. Antibacterial efficacy of calcium 
hydroxide intracanal dressing: a systematic review and meta-
analysis. International Endodontic Journal, 2007, 40, 2–10. 
 
11. Carlos Estrela, Rosane Galhardo Ribeiro, Cyntia R.A. Estrela, 
Jesus Djalma Écora, Manoel Damião Sousa-Neto.  Antimicrobial 
Effect of 2% Sodium Hypochlorite and 2% Chlorhexidine Tested 
by Different Methods. Braz Dent J, 2003, 14(1): 58-62. 
 
12. Carounanidy Usha, Satyanarayanan R, Velmurugan A. Use of an 
aqueous extract of Terminalia chebula as an anticaries agent: A 
clinical study. Indian Journal of Dental Research, 2007,            
18(4), 152-156. 
 
13. Charles H. Stuart, Scott A. Schwartz, Thomas J. Beeson, and 
Christopher B. Owatz. Enterococcus faecalis: Its Role in Root 
Canal Treatment Failure and Current Concepts in Retreatment. 
JOE — February 2006, Volume 32, Number 2. 
 
14. Chattopadhyay, Bhattacharyya. Plant Review: Terminalia chebula: 
An update. Pharmacognosy Reviews, Jan- May, 2007, Vol 1,     
Issue 1. 
 
15. Ching S. Wang, Roland R. Arnold, Martin Trope and Fabricio B. 
Teixeira. Clinical Efficiency of 2% Chlorhexidine Gel in Reducing 
Intracanal Bacteria. JOE — 2007, Volume 33, Number 11. 
 
16. Chong, B S : Pitt Ford, T R. The role of intracanal medication in 
root canal treatment.IEJ. 1992 Mar; 25(2): 97-106. 
 
17. Collee JG, Miles RS, Watt B, Tests for the identification of 
bacteria. In Mackie & McCartney Practical Medical Microbiology, 
14th Edition, Collee JG, Fraser AG, Marmion BP, Simmons A. 
Eds. (Churchill Livingstone Inc. New York) 1996: 131-149. 
 
18. Cruz, K. Kota, J. Huque, M. Iwaku, E. Hoshino. Penetration of 
propylene glycol into dentine. International Endodontic Journal, 
2002, 35, 330–336.  
 77 
 
19. Edgar Schäfer, and Klaus Bössmann, Antimicrobial Efficacy of 
Chlorhexidine and Two Calcium Hydroxide Formulations against 
Enterococcus faecalis. Journal Of Endodontics, January 2005, Vol. 
31, No. 1; 53-56. 
 
20. Elizabeth. K.M.  Antimicrobial Activity Of Terminalia Bellerica, 
Indian Journal of Clinical Biochemistry, 2005, 20 (2) 150-153. 
 
21. Ertug˘rul Ercan, Mehmet Dalli and Ç. Türksel Dülgergil, Kırıkkale 
and Diyarbakır. In vitro assessment of the effectiveness of 
chlorhexidine gel and calcium hydroxide paste with chlorhexidine 
against Enterococcus faecalis and Candida albicans. Oral Surg Oral 
Med Oral Pathol Oral Radiol Endod 2006;102:e27-e31. 
 
22. Evans M, Davies JK, Sundqvist G, Figdor D. Mechanisms 
involved in the resistance of Enterococcus faecalis to calcium 
hydroxide. Int Endod J 2002;35:221– 8. 
 
23. Fabiane Bortoluci da Silva, Juliano Milanezi de Almeida, Simone 
Maria Galvão de Sousa. Natural medicaments in endodontics – a 
comparative study of the anti-inflammatory action. Braz Oral Res, 
2004;18(2):174-9. 
 
24. Fava LRG, Saunders WP. Calcium hydroxide pastes: classification 
and clinical indications. Int Endod J 1999;32:257–82. 
 
25. Ferrari, Cai, Bombana. Effect of endodontic procedures on 
enterococci, enteric bacteria and yeasts in primary endodontic 
infections. International Endodontic Journal, 2005, 38, 372–380. 
 
26. Francisco José de Souza-Filho, Adriana de Jesus Soares, Morgana 
Eli Vianna, Alexandre Augusto Zaia, Caio Cezar Randi Ferraz, 
Brenda Paula Figueiredo de Almeida Gomes. Antimicrobial Effect 
and pH of Chlorhexidine Gel and Calcium Hydroxide Alone and 
Associated with other Materials. Braz Dent J. 2008, 19(1): 28-33. 
 
27. Garcez AS, Nunez SC, Lage-Marques JL, Hamblin MR, Ribeiro 
MS. Photonic real-time monitoring of bacterial reduction in root 
canals by genetically engineered bacteria after chemomechanical 
endodontic therapy. Braz Dent J. 2007;18:202–7. 
 
 78 
28. George, Kishen, BDS, MDS, PhD, and K. P. Song, BDS, PhD. The 
Role of Environmental Changes on Monospecies Biofilm 
Formation on Root Canal Wall by Enterococcus faecalis. JOE, 
December 2005, Volume 31, Number 12. 
 
29. Giovanna Pires da Silva Ribeiro de Rezende, Luciane Ribeiro de 
Rezende Sucasas da Costa, Fabiana Cristina Pimenta, Daniela 
Abrão Baroni. In vitro Antimicrobial Activity of Endodontic Pastes 
with Propolis Extracts and Calcium Hydroxide: A Preliminary 
Study. Braz Dent J. 2008, 19(4): 301-305. 
 
30. Gomes BPFA, Vianna ME, Senna NT, Zaia AA, Ferraz CCR, 
Souza-Filho FJ. In vitro evaluation of the antimicrobial activity of 
calcium hydroxide combined with chlorhexidine gel used as 
intracanal medicament. Oral Surg Oral Med Oral Pathol Oral 
Radiol Endod. 2006;102:544-550. 
 
31. Gomes, Ferraz, Garrido, Rosalen. Microbial susceptibility to 
Ca(OH)2 pastes and their vehicles. J Endod. 2002;28:758-61. 
 
32. Gomes, Lilley &. Drucker. Variations in the susceptibilities of 
components of the endodontic microflora to biomechanical 
procedures. IEJ. 1996, 29 (4), 235-241. 
 
33. Gomes, Pinheiro, Gade-Neto, et al. Microbiological examination of 
infected dental root canals. Oral Microbiol Immunol, 2004;    
19:71– 6. 
 
34. Gomes, Souza, Ferraz, Teixeira, Zaia, Valdrighi & Souzo-Filho. 
Effectivenss of 2% chlorhexidine gel and calcimm hydroxide 
against Enterococcus faecalis in Bovine root dentine in vitro. 
International Endodontic Journal, 2003, 36, 267-275. 
 
35. Haapasalo, Orstavik. In vitro Infection and Disinfection of Dentinal 
Tubules, Journal of Dental Research, 1987; 66(8):1375-1379. 
 
36. Hancock HH, Sigurdsson A, Trope M, Moiseiwitsch J. Bacteria 
isolated after unsuccessful endodontic treatment in a North Am 
population. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 
2001; 91:579–86. 
 
37. Heling I, Steinberg D, Kenig S, Gravilovich I, Sela MN, Friedman 
M. Efficacy of sustained-release device containing chlorhexidine 
 79 
and Ca(OH)2 in preventing secondary infection of dentinal tubules. 
Int Endod J, 1992;25:20-4. 
 
38. Hyun-Sun LEE, Nam Hee WON, Kyoung Heon KIM, Hojoung 
LEE, Woojin JUN, and Kwang-Won LEE. Antioxidant Effects of 
Aqueous Extract of Terminalia chebula in Vivo and in Vitro. Biol. 
Pharm. Bull. 2005, 28(9) 1639—1644. 
 
39. Iqbal Ahmad, Zafar Mehmood, Faiz Mohammad. Screening of 
some Indian medicinal plants for their antimicrobial properties. 
Journal of Ethnopharmacology. 1998, 62, 183–193. 
 
40. Isabelle Portenier, Tuomos M.T. Waltimo & Markus Haapasalo. 
Enterococcus faecalis – the root canal survivor and ‘star’ in 
posttreatment disease. Endodontic Topics, 2003, 6, 135–159.  
 
41. Jagtap AG, Karkera SG. Potential of the aqueous extract of 
Terminalia chebula as an anticaries agent. Journal of 
Ethnopharmacology, 1999;68:299-306. 
 
42. Jayaramkumar. Effect of geographical variation on content of 
tannic acid, gallic acid, chebulinic acid, and ethyl gallate in 
Terminalia chebula fruits. Natural Products, 2006, 2(3-4) : 170-5. 
 
43. Jeena K. Jose, Girija Kuttan, Ramadasan Kuttan. Antitumour 
activity of Emblica officinalis. Journal of Ethnopharmacology, 
2001,75, 65–69. 
 
44. Jogikalmat Krithikadatta, Rajamani Indira,  Alfred Leo 
Dorothykalyani. Disinfection of Dentinal Tubules with 2% 
Chlorhexidine, 2% Metronidazole, Bioactive Glass when 
Compared with Calcium Hydroxide as Intracanal Medicaments. 
JOE — December 2007, Volume 33, Number 12. 
 
45. Josd F. Siqueira, Jr., DDS, MSc, and Milton de Uzeda, DDS, MSc, 
DSc. Intracanal Medicaments: Evaluation of the Antibacterial 
Effects of Chlorhexidine, Metronidazole, and Calcium Hydroxide 
Associated with Three Vehicles. Journal of Endodontics, 1997; 
23(3):167-169 
 
46. Jung IY, Seo MA, Spångberg LSW, et al. Apical anatomy in 
mesial and mesiobuccal roots of permanent first molars. J Endod 
2005;31:364–8. 
 80 
 
47. Kakehashi S, Stanley HR, Fitzgerald RJ. The effects of surgical 
exposures of dental pulps in germ-free and conventional laboratory 
rats. Oral Surg Oral Med Oral Pathol, Sep 1965, 20(3):340-49. 
 
48. Kayaoglu, Erten & Ørstavik. Growth at high pH increases 
Enterococcus faecalis adhesion to collagen. International 
Endodontic Journal, 2005, 38, 389–396. 
 
49. Kihio C. Lima, Luis R. G. Fava, and Jose F. Siqueira Jr., DDS, 
MSc, PhD.  Susceptibilities of Enterococcus f'ecalis Biofilms to 
Some Antimicrobial Medications. Journal of Endodontics, 2001, 
Vol. 27(10); 616-618. 
 
50. Komorowski R, Grad H, Wu XY, Friedman S. Antimicrobial 
substantivity of chlorhexidine-treated bovine root dentin. J Endod 
2000;26:315-7. 
 
51. Kumar, Kirubanandan, Sripriya, Sehgal. Triphala promotes healing 
of infected full-thickness dermal wound. J Surg Res, January 2008, 
Vol. 144, No. 1, pp. 94-101. 
 
52. Lenet BJ, Komorowski R, Wu XY, Huang J, Grad H, Lawrence 
HP, et al. Antimicrobial substantivity of bovine root dentin 
exposed to different chlorhexidine delivery vehicles. J Endod 
2000;26:652-5. 
 
53. Lisane Paquette, DMD, MSc, Milos Legner, PhD, Edward D. 
Fillery, PhD, and Shimon Friedman, DMD. Antibacterial Efficacy 
of Chlorhexidine Gluconate Intracanal Medication In Vivo. JOE— 
July 2007, Volume 33, Number 7. 
 
54. Love, Jenkinson. Invasion of dentinal tubules by oral bacteria. 
Critical Reviews in Oral Biology & Medicine. 2002, 13(2):171-
183. 
 
55. Love. Enterococcus faecalis – a mechanism for its role in 
endodontic failure. International Endodontic Journal, 2001, 34, 
399–405. 
 
56. Marjorie MurphyCowan. Plant Products as Antimicrobial Agents. 
Clinical Microbiology Reviews, 1999, Oct, 564-582. 
 
 81 
57. Manzur A, González AM, Pozos A, Silva-Herzog D, Friedman S. 
Bacterial quantification in teeth with apical periodontits related to 
instrumentation and different intracanal medications: a randomized 
clinical trial. J Endod 2007;33:114–8. 
 
58. Markus Haapasalo, Trude Udnæs, & Unni Endal. Persistent, 
recurrent, and acquired infection of the root canal system post-
treatment. Endodontic Topics 2003, 6, 29–56. 
 
59. Markus Haapasalo,Wei Qian, Isabelle Portenier,Tuomas Waltimo. 
Effects of Dentin on the Antimicrobial Properties of Endodontic 
Medicaments. JOE —August 2007, Volume 33, Number 8. 
 
60. Minkyun, Wan, Kang, Min, Yoo, Yuk, Yu-Ichiro, Sciichi, 
Nobuhiko. Cytoprotective effect on oxidative stress and inhibitory 
effect on cellular aging of Terminialia chebula fruit. Phytother Res. 
2004, 18 : 737-41. 
 
61. Molander A, Reit C, Dahlen G, Kvist T. Microbiological status of 
root-filled teeth with apical periodontitis. Int Endod J, 1998;31:1–
7. 
 
62. Na, Bae, Keng, Min, Yoo, Kamiryo, Senoo, Yokoo, Miwa. 
Cytoprotective effect on oxidative stress and inhibitory effect on 
cellular aging of Terminalia chebula fruit. Phytother Res. 2004 
18(9) : 737-41. 
 
63. Naik, Priyadarsini, Naik, Gangabhagirathi, H. Mohan. Studies on 
the aqueous extract of Terminalia chebula as a potent antioxidant 
and a probable radioprotector. Phytomedicine. 2004, 11 530–538. 
 
64. Oguntebi. Dentine tubule infection and endodontic therapy 
implications. IEJ, 1994 Volume 27 Issue 4, Pages 218 - 222. 
 
65. Ohara P, Torabinejad M, Kettering JD. Antibacterial effects of 
various endodontic irrigants on selected anaerobic bacteria. Endod 
Dent Traumatol, 1993;9:95-100. 
 
66. Ørstavik D, Kerekes K, Molven O. Effects of extensive apical 
reaming and calcium hydroxide dressing on bacterial infection 
during treatment of apical periodontitis: a pilot study. Int Endod J, 
1991;24:1-7. 
 
 82 
67. Peciuliene V, Balciuniene I, Eriksen H, Haapasalo M. Isolation of 
Enterococcus faecalis in previously root-filled canals in a 
Lithuanian population. J Endod, 2000;26:593–5. 
 
68. Peciuliene V, Reynaud AH, Balciuniene I, Haapasalo M. Isolation 
of yeasts and enteric bacteria in root-filled teeth with chronic apical 
periodontitis. Int Endod J 2001;34:429 –34. 
 
69. Peters OA, Schönenberger K, Laib A. Effects of four Ni-Ti 
preparation techniques on root canal geometry assessed by micro 
computed tomography. Int Endod J, 2001;34:221–30. 
 
70. Pinheiro ET, Gomes BPFA, Ferraz CCR, Sousa ELR, Teixeira FB, 
Souza Filho FJ. Microorganisms from canals of root-filled teeth 
with periapical lesions. Int Endod J, 2003;36:1–11. 
 
71. Pinheiro ET, Gomes BPFA, Ferraz CCR, Teixeira FB, Zaia AA, 
Souza-Filho FJ. Evaluation of root canal microorganisms isolated 
from teeth with endodontic failure and their antimicrobial 
susceptibility. Oral Microbiol Immunol, 2003;18:100 –3. 
 
72. Portenier I, Waltimo T, Ø’ rstavik D, Haapasalo M. The 
susceptibility of starved stationary phase, and growing cells of 
Enterococcus faecalis to endodontic medicaments. J Endod, 
2005;31:380 –5. 
 
73. Portenier, H.Haapasalo, A. Rye, T. Waltimo, D. Ørstavik &         
Haapasalo. Inactivation of root canal medicaments by dentine, 
hydroxylapatite and bovine serum albumin. International 
Endodontic Journal, 2001, 34; 184–188. 
 
74. Prasanna Neelakantan, Kavitha Sanjeev, C. V. Subbarao. Duration-
dependent susceptibility of endodontic pathogens to calcium 
hydroxide and chlorhexidene gel used as intracanal medicament: an 
in vitro evaluation. Oral Surg Oral Med Oral Pathol Oral Radiol 
Endod, 2007;104:e138-e141. 
 
75. Rasool, Sabina. Antiinflammatory effect of the Indian Ayurvedic 
herbal formulation Triphala on adjuvant-induced arthritis in mice. 
Phytother Res. 2007 Sep;21(9):889-94. 
 
 83 
76. Rege, Thatte, Dahanukar. Adaptogenic properties of six rasayana 
herbs used in Ayurvedic medicine. Phytotherapy Research 
1999;13:275-291. 
 
77. Ritch-Kro, Turner. Carrier herbal medicine : an evaluation of the 
antimicrobial and anti cancer activity in some frequently used 
remedies. J. Ethno. Pharmacol. 1996, 5, 151-156. 
 
78. Rôças IN, Siqueira JF, Santos KRN. Association of Enterococcus 
faecalis with different forms of periradicular diseases. J Endod, 
2004;30:315–20. 
 
79. Sabu, R. Kuttan. Antidiabetic activity of medicinal plants and its 
relationship with their antioxidant properties. J. Ethnopharmacol. 
2002, 81 : 155-60. 
 
80. Saleem , M. Husheem , P. Harkonen , K. Pihlaja. Inhibition of 
cancer cell growth by crude extract and the phenolics of Terminalia 
chebula Retz. Fruit. J. Ethnopharmacol. 2002, 81 : 327-36. 
 
81. Sayanti Bhattacharya, Susri R. Chaudhuri, Subrata Chattopadhyay, 
and Sandip K. Bandyopadhyay. Healing Properties of Some Indian 
Medicinal Plants against domethacin-Induced Gastric Ulceration of 
Rats. J. Clin. Biochem. Nutr., September 2007,  41, 106–114. 
 
82. Shabahang S, Pouresmail M, Torabinejad M. In vitro antimicrobial 
efficacy of MTAD and sodium hypochlorite. J Endod, 2003; 
29:450 –2. 
 
83. Shigetaka Nagaoka, DDS, PhD, Youichi Miyazaki, DDS, Hong-Jih 
Liu, DDS, PhD, Yuko Iwamoto, DDS, Motoo Kitano, DDS, PhD, 
and Masataka Kawagoe, DDS, PhD. Bacterial Invasion into 
Dentinal Tubules of Human Vital and Nonvital Teeth. Journal Of 
Endodontics, February 1995, Vol. 21, No. 2. 
 
84. Shin , H.J. Jeong , D.K. Kim , S.H. Kim , J.K.Lee ,A.K. Kim , 
B.S.Chae, Kang HW, Lee CM, Lee KC, Park ST, Lee EJ, Lim JP, 
Kim HM, Lee YM. Inhibitory action of water soluble fraction of 
Terminalia chebula on systematic and local anaphylaxis. J. 
Ethnopharmacol. 2001, 74 : 133-40. 
 
 84 
85. Siqueira JF, Rôças I. Polymerase chain reaction-based analysis of 
microorganisms associated with failed endodontic treatment. Oral 
Surg Oral Med Oral Pathol Oral Radiol Endod, 2004;97:85–94. 
 
86. Srikumar, Jeya Parthasarathy, Shankar, Manikandan, Vijayakuma, 
R. Thangaraj, Sugina, Sing, Sivakumar, Sampath, Chandrakasan. 
Influence of Terminalia chebula on dermal wound healing of rats. 
Phytother Res. 2002, 16 :227-31. 
 
87. Srikumar, Jeya Parthasarathy, Shankar, Manikandan, Vijayakumar,  
Thangaraj, Vijayananth, Sheeladevi and Usha Anand Rao. 
Evaluation of the Growth Inhibitory Activities of Triphala against 
Common Bacterial Isolates from HIV Infected Patients. Phytother. 
Res. 2007, 21, 476–480. 
 
88. Sundqvist G, Figdor D, Persson S, Sjogren U. Microbiologic 
analysis of teeth with failed endodontic treatment and the outcome 
of conservative re-treatment. Oral Surg Oral Med Oral Pathol Oral 
Radiol Endod, 1998;85:86 –93. 
 
89. Tandjung, Waltimo, Hauser, Heide, Decker, Weiger. Octenidine in 
root canal and dentine disinfection ex vivo. International 
Endodontic Journal, 2007, 40, 845–851. 
 
90. Tasduq, Singh, Satti, Gupta, Suri and Johri. Terminalia chebula 
(fruit) prevents liver toxicity caused by sub-chronic administration 
of rifampicin, isoniazid and pyrazinamide in combination. Human 
& Experimental Toxicology, 2006, 25: 111-118. 
 
91. Thomas R. Dunavant, DDS, John D. Regan, B.DentSc, MSc, MS, 
Gerald N. Glickman, DDS, MS, MBA, Jd, Eric S. Solomon, MA, 
DDS, and Allen L. Honeyman, PhD. Comparative Evaluation of 
Endodontic Irrigants against Enterococcus faecalis Biofilms. JOE 
— June 2006, Volume 32, Number 6. 
 
92. Vijayananth, Sheeladevi and Usha Anand Rao. Evaluation of the 
Growth Inhibitory Activities of Triphala against Common Bacterial 
Isolates from HIV Infected Patients. Phytother. Res. 2007,           
21, 476–480.  
 
93. Vivacqua-Gomes, Gurgel-Filho, Gomes, Ferraz, Zaia, Souza-Filho. 
Recovery of Enterococcus faecalis after single- or multiple-visit 
 85 
root canal treatments carried out in infected teeth ex vivo. 
International Endodontic Journal, 2005, 38, 697–704. 
 
94. Vonshak,  Barazani,  Sathiyomoorthy,  Shalev,  Vardy,  Golan- 
goldhirsh. Screening of South-Indian medicinal plants for anti-
fungal activity. Phyther. Res. 2003, 17(9) : 1123-5. 
 
95. Walton, Simon, Bhat, Francis. Effect of four vehicles on the pH of 
calcium hydroxide and the release of calcium ion. Oral Surgery, 
Oral Medicine, Oral Pathology, Oral Radiology, and 
Endodontology, Volume 80, Issue 4, Pages 459-464. 
 
96. White RR, Hays GL, Janer LR. Residual antimicrobial activity 
after canal irrigation with chlorhexidine. J Endod, 1997;23:229- 31. 
 
97. Wilma Brugger, Vera Hofer, Peter Städtler. Antibacterial Effects of 
Endodontic Dressings on Enterococcus Faecalis in Human Root 
Dentine. Acta Stomatol Croat. 2007;41(4):326-336. 
 
98. Yogesh S. Biradar, Sheetal Jagatap, K. R. Khandelwal and Smita 
S. Singhania. Exploring of Antimicrobial Activity of Triphala 
Mashi—an Ayurvedic Formulation. Exploration of Antimicrobial 
Activity of Triphala Mashi. eCAM. 2008;5(1)107–113. 
 
 
